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Abstract 
Background: It is well documented that the American maternal mortality ratio has 
increased during the last two decades. The Australian maternal mortality ratio, in contrast, 
has decreased during the same time period, a trend common amongst most Western 
countries.  
Objective: To determine if there is a similar rate of preventable maternal death in the 
Ochsner Health System (OHS; Louisiana) and the Queensland Health System (QHS; 
Australia) and if the deaths were attributable to the same factors.  
Study Design: Retrospective cohort study of cases of in-hospital maternal deaths within the OHS 
and QHS from 1995 to 2013. Charts for each case of maternal mortality were presented to a 
multidisciplinary team who reached a consensus on whether the death was preventable, potentially 
preventable or not preventable based on the most widely accepted definition of preventable 
maternal mortality. The team reached a majority decision on whether the death was complicated 
by provider-, systems- or patient-based factors or some combination thereof, and on whether the 
woman entered her pregnancy in a healthy state or with minor or major morbidity. 
Results: There were 16 eligible charts identified within the OHS and 15 within the QHS. Sixty-two 
point five percent of the American women and 50.0% of the Australian women entered pregnancy 
with major morbidity (absolute risk difference (RD)=12.5% 95% CI: (-22.8, 47.8); P=0.49). Seventy-
five percent of American and 73.3% of Australian deaths were deemed potentially preventable.  
In the American cohort, the incidence of preventable and overall maternal death was 
higher if the patient had late entry to prenatal care (IRR= 8.8, P=0.004, (IRR=6.3, 
P=0.004), respectively). Maternal mortality in the American cohort was also higher if the 
patient required transfer to the OHS (IRR=15.8, P<0.001). Deaths in the American group 
with private insurance were more likely to be not preventable (P=0.003). Uninsured 
patients had the highest MMR, with an IRR of 13.8 (P=0.014) compared to Medicaid 
patients.  
Australian maternal mortality, both overall and preventable, could not be statistically linked 
to any of the demographic characteristics examined.  
When comparing the 2 cohorts, there was a statistically significant difference between the 
Australian and American cohorts regarding late or no entry into prenatal care, RD=44.5 
overall (95% CI 9.7, 79.4; P=0.03) and 50.0% for potentially preventable deaths (CI 9.3%, 
90.6%; P=0.04), both favoring the Australian cohort.  
Conclusion: In this study, the two cohorts have similar rates of preventable maternal 
death, but different influences exist. Although there were no statistically significant factors 
to explain trends in Australian maternal, American maternal mortality was statistically 
significantly correlated with point of entry into prenatal care when compared to both 
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American women receiving routine prenatal care and Australian women overall. Many 
factors contribute to when a woman first seeks prenatal care, including her insurance 
status. The American cohort showed an increasing incidence of preventable maternal 
death going from private insurance to Medicaid to being uninsured. Furthermore, the 
majority of deaths in women with late or no prenatal care were complicated by systems-
based factors, such as communication between providers, departments and hospitals.  
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1. INTRODUCTION 
In 2000, when United Nations (UN) Millennial Development Goal (MDG) 5 was 
identified as demonstrating the slowest worldwide progress, a global commitment was 
made to achieve its 2 parts: a 75% reduction in maternal mortality ratio (MMR) from 1990-
2015 and provision of universal access to reproductive health (Trends in maternal 
mortality: 1990 to 2015, 2015). Understandably, much of the effort to reduce maternal 
mortality has been in countries where it is highest. These countries tend to be clustered in 
the Middle East and Sub-Saharan Africa but are also scattered throughout Asia and the 
Caribbean. In the years leading up to 2015, a number of initiatives commenced in order to 
hone these efforts. And a new forward-looking goal was created: the global reduction in 
MMR to less than 70 maternal deaths per 100,000 live births by the year 2030.  
MMR is defined as maternal deaths per 100,000 live births, where maternal death 
according to the International Statistical Classification of Diseases, 10th Edition (ICD-10) is 
“the death of a woman while pregnant or within 42 days of termination of pregnancy, 
irrespective of the duration or site of the pregnancy, from any cause related to or 
aggravated by the pregnancy or its management but not from accidental causes.” This 
leaves the scope of maternal deaths counted in the World Health Organisation (WHO) 
estimates quite large. For example, a suicide as a sequela to postpartum depression 
occurring 4 weeks after delivery would be included. Human immunodeficiency virus (HIV)-
related deaths that occur within this specified timeframe would be included as well (Riffe, 
2010). The WHO also collects data on late maternal death (occurring 42-365 days after 
delivery) and pregnancy-associated death (which uses the 42-day timeline), but includes 
all causes of death, even those not related to pregnancy. It should be noted that within the 
United States, the Centers for Disease Control (CDC) uses the pregnancy-related mortality 
ratio, which includes late maternal deaths occurring up to 1 year after the resolution of 
pregnancy. The candidate chose to use the WHO definition of MMR to compare America’s 
maternal mortality to that in other countries, such as Australia.  
In addition to MMR, maternal mortality rate (MMRate) and the proportion of 
maternal deaths of females of reproductive age (PMDF) are two other indicators of the 
maternal health of a country. PMDF gives an indication of how highly maternal mortality 
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weighs into all-cause mortality for females of reproductive age. For example, if country X 
has a very high rate of motor vehicle deaths amongst women of reproductive age but a 
very small rate of maternal deaths, it would have a low PMDF. MMRate gives an indication 
about the maximal room for improvement in maternal care. Decreases in fertility will lower 
PMDF and MMRate, but not MMR. In this way, MMR becomes the most widely used 
measure because it removes extraneous influences on maternal health. Box 1 shows how 
each of these metrics is calculated. 
 
MMR = Maternal DeathsLive Births  
MMRate = Maternal DeathsFemales15− 49  
PMDF = Maternal DeathsAll Deaths, Females15− 49  
 
 
Estimates of MMR are made every 3-5 years by an interagency group comprised of 
the WHO, the United Nations Children’s Fund (UNICEF), the United Nations Population 
Fund (UNFPA), World Bank Group and the UN Population Division. These estimates rely 
on country-specific data reporting of 2 metrics: maternal deaths and live births. Generally, 
4 types of data sources exist: civil registration and vital statistics (CRVS), specialized 
studies, other data sources reporting pregnancy-related mortality and other data sources 
reporting maternal mortality. The latter 2 can be in the form of household surveys or 
census data, for example. CRVS is the primary and preferred source of data as it relies on 
Box 1: MMR, MM Rate and PMDF 
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the mandatory reporting of maternal deaths; however, some countries do not have the 
infrastructure for such a system or have a system in place that does not take the entire 
nation into account.  
While a CRVS system appears ideal, it often suffers from unrecorded or 
misreported maternal death, leading to underreporting. This has led the WHO interagency 
group to also report the usability of maternal death records and an adjustment factor by 
which to multiply the total MMR to garner a more accurate estimate. The adjustment factor 
is based on the frequency with which maternal deaths are reported, if years are skipped 
between years of reporting, and if the country conducted specialized studies to refine its 
MMR. The value of the adjustment factor is also based on previous estimates of the 
country’s MMR. Uncertainty estimates are also calculated based on the amount and 
quality of the data provided. The hallmark specialized study into MMR comes from the 
United Kingdom, where the Ministry of Health conducts a Confidential Enquiry into 
Maternal and Child Health (CEMACH) to refine national estimates every 3 years (Swanton, 
2009). The results of this enquiry lead to the publication of recommendations for health 
care practitioners to follow. For example, recent enquiries have pointed out the need for an 
obstetric early-warning system to monitor subtle patient decline.  
Within the developing world, HIV and acquired immunodeficiency syndrome (AIDS) 
are perhaps the largest determinants of maternal death. When they created the statistical 
model of MMR calculation, the WHO interagency group took this into account, calculating 
MMR as  
MMR = non-AIDS-related MMR + AIDS-related indirect MMR 
where the first variable represents maternal deaths with direct obstetric causes or indirect 
obstetric causes not complicated by HIV and the second variable represents AIDS-related 
deaths where the patient’s state was aggravated by being pregnant. Direct maternal 
deaths are defined as those deaths occurring as a result of obstetric complications of the 
pregnancy state. Indirect deaths are those that result from a pre-existing disease or 
disease state that developed during pregnancy, where death was not from direct obstetric 
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causes, but which may have been aggravated by pregnancy. Incidental deaths are those 
occurring during the pregnancy or puerperium but are unlikely to be related to the death.  
In Queensland, the Queensland Maternal and Perinatal Quality Council (QMPQC) 
examined maternal mortality state-wide from 2004-2008. Of the 11 deaths state-wide, 3 
were direct maternal deaths (27%), 6 were indirect maternal deaths (55%), and 2 were 
incidental (18%). Of the 28 deaths occurring within 42 days postpartum, 11 were direct 
(39%), 9 were indirect (32%) and 8 were incidental (29%). There were 43 late maternal 
deaths of the 82 total deaths identified (QMPQC, 2011).  
 In Louisiana, the Maternal and Child Health (MCH) Program completed its 
Pregnancy Associated Mortality Review (PAMR) and the only one to date. This review 
looked at all maternal deaths from January 1st to December 31st, 2008. 50 deaths were 
determined to be pregnancy-associated, defined as a death occurring while pregnant or 
within one year of pregnancy termination, regardless of the outcome. 17 of these deaths 
were considered to be pregnancy-related, defined as a “(1) complication of the pregnancy 
itself; (2) chain of events initiated by pregnancy that led to death; or (3) effect of pregnancy 
caused the aggravation of an unrelated condition that subsequently caused death.” 
Furthermore 12% (6) of these deaths occurred antepartum and 26% (13) occurred 
between 0-59 days after the termination of pregnancy.  
 38% of these 50 pregnancy-associated deaths were from “natural or medical 
causes”, 30% were from unintentional injury (including accident and substance abuse) and 
24% were due to homicide. Accidental injury and homicide were the far leading causes of 
pregnancy-associated death, at 26% and 24% respectively. Injury causes of pregnancy-
associated mortality can be divided into homicide, suicide and accidental injury. For 
homicide, which forms 42.9% of this category, discharge of a firearm is 32.1% of overall 
and sharp object is 10.7% of overall mortality in the subcategory. Of suicide, which forms 
11% of this subcategory, 7.1% is by drug overdose and 3.6% is by discharge of firearm. Of 
accidental injury, which forms 46% of injury causes, MVA occupant is 28.6%, MVA 
pedestrian is 7.1% and smoke inhalation and accidental poisoning are the other 10.7% 
(Maupin, 2010). 
 In Queensland, suicide forms the majority of indirect deaths occurring during 
pregnancy and in the 42 days postpartum. It also formed the majority of deaths occurring 
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in the late maternal period (43 days to one year postpartum; 11 of the 43 deaths or 26%). 
This was followed by malignancy with 8 of 43 deaths or 19%. None of the indirect or 
incidental deaths occurring during pregnancy or in the puerperium were caused by 
homicide or violence.  
 This study looks solely at direct and indirect causes of maternal mortality during 
pregnancy and in the 42 days postpartum. The candidate did not examine suicide nor 
violent deaths as these almost always occur outside the hospital settings. In regards to 
medical cause of death, cardiovascular disease formed 47.1% of the medical causes of 
maternal mortality in Louisiana in 2008, this excludes pulmonary embolism, which formed 
11.8%. In Queensland, thromboembolism was the leading cause, with 4 of the 14 direct 
maternal deaths occurring either during pregnancy or in the 42 days postpartum (29%). 
Amniotic fluid embolism and haemorrhage were the next most common, with 3 of 14 
deaths or 21% each. 
In regard to the 2 countries studied here, both Australia and the United States have 
commendable CRVS and low rates of HIV compared to developing countries. Yet in 2015, 
the reported MMR for the United States was 14, more than twice that of Australia. In fact, 
American MMR increased in an almost linear fashion during the period 1995-2015. During 
the same period, Australian MMR decreased in a similarly linear fashion, with a baseline 
rate of 6 deaths per 100,000 live births reached for the period 2005-2013. Australia’s 
progression with respect to improving its MMR mirrors that of many Western countries, 
excluding the United States. This thesis is a retrospective cohort study that sought to 
illuminate possible causes for the high American MMR. Populations included in the study 
are indigenous and non-indigenous residents of the state of Queensland who used the 
Queensland Health System (QHS) and residents of the Gulf South who used the Ochsner 
Health System (OHS) as their primary sources of obstetric care. 
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2. BACKGROUND 
2.1 Trends in maternal mortality: The United States and Australia  
Although 2 of the wealthiest countries in the world1, Australia and the United States 
have grossly different MMRs, stemming from a divergent trend dating back to 1995 
(Worldbank, 2016). 
 
Fig 1: USA MMR and PM 1985 - 2015. Reproduced with permission from 
Trends in maternal mortality: 1990 to 2015, World Health Organization, 2016.  
 
The United States is the only developed country to show an increase in MMR 
between 1990 and 2015, rising from 12 to 14, a 16.7% increase (Trends in maternal 
mortality: 1990 to 2015, 2015). Figure 1 shows MMR for the years of interest (left) and 
proportion of maternal deaths among deaths of females of reproductive age (PM%; right). 
Data from the CDC’s pregnancy mortality surveillance system, the United States’ 
equivalent of a CRVS, were used for MMR calculations. Uncertainty estimations are given 
by the shaded portions of the graph. Australian estimates are also provided by CVRS data. 
                                                
1. As measured by gross domestic product (GDP) per capita, purchasing power parity 
(PPP) for the period 2009 - 2013 (in current international $, which has the same 
purchasing power as the US dollar has in the USA. USA = $51,749, Australia = $43, 
818.) Source: World Bank 
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(Fig. 2) A comprehensive comparison of causes of MMR in Western countries where HIV 
is not a major comorbidity has not been conducted. The lack of data on this subject 
justifies its necessity. 
 
Fig 2: Australian MMR and PM 1985 - 2015. Reproduced with permission from 
Trends in maternal mortality: 1990 to 2015, World Health Organization, 2016. 
Besides being a very real trend, a disturbing number of maternal deaths are 
considered preventable by experts, and a disparate amount of these deaths affect minority 
groups within the United States. According to Kilpatrick et al., “By the late 1990s, it was 
apparent that maternal mortality in the United States was no longer declining, was 
underestimated, and was disproportionately affecting certain groups of women, and as 
many as 37%-54% of the deaths were likely preventable. A large black/white disparity in 
maternal deaths continues” (Kilpatrick et al., 2012).  
2.2 Calculating MMR–United States  
A factor that may confound the true detection of an upward trend in American MMR 
is the way in which MMR is calculated. One study attributes the increase in American 
MMR to the identification of late maternal deaths by the ICD-10 (occurring more than 42 
days but less than 1 year after delivery) and the inclusion of a separate pregnancy 
question as a standard item on the US Standard Certificate of Death (Hogan et al., 2010). 
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However, this is an incomplete explanation. The change to ICD-10 on a national level 
occurred in 1999 and is thought to be attributable to about 13% of the increase in MMR 
between 1998-1999. In addition, a separate pregnancy question was included in the US 
Standard Certificate of Death in 2003, asking whether the woman was pregnant when she 
died, had been pregnant within 42 days of her death, or had been pregnant greater than 
42 days prior but less than a year from her death (Hoyert, 2007). Between 2002-2003, 
MMR increased 40% for states with a separate question and 53% for states without a 
separate question about maternal deaths before 2003. This is a possible explanation for 
some of the increase in American MMR from 2002-2003. Notably, Louisiana–the state of 
interest in this study–had a separate question on its death certificate about pregnancy 
before 2003 and thus, this alone could not explain the rising MMR in this state. A more in-
depth discussion about maternal mortality in Louisiana follows. Finally, neither factor can 
justify the increase in maternal mortality from 2003 onward.  
There is a significant body of literature about how MMR is calculated in various 
countries and how to improve these calculations. When data collection for this project 
commenced in 2013, American MMR was estimated to be 28/100,000 (Trends in maternal 
mortality: 1990 to 2013, 2013). When the project was finishing in mid-2016, the same 
interagency group amended previous estimates, stating the new American maternal 
mortality for those years was 14/100,000 and issuing the statement, “the results described 
in this report are the most accurate maternal mortality estimates yet for all years in the 
1990-2015 period. Therefore, these 2015 estimates should be used for the interpretation 
of trends in MMR from 1990 to 2015, rather than extrapolating estimates from previously 
published estimates” (Trends in maternal mortality: 1990 to 2015, 2015). American 
estimates were felt by the interagency group to be 95%-97% useable for the years in 
question. As well, the newly estimated range of uncertainty was 12-16 maternal deaths per 
100,000 live births in 2015. Notably, Australian estimates were virtually unchanged 
between these 2 publications.  
While it would be impossible to produce reliable data about the aetiology of 
American MMR without accurate estimates of MMR trends, the concern of this paper is 
why American MMR is higher than that of another Western country and shows a 
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continually increasing trend. In this way, the study aimed to inform clinicians, not 
statisticians, about a trend that is going largely unnoticed. 
2.3 Calculating MMR–Louisiana  
Louisiana is consistently recognized as a state with one of the highest MMRs in the 
United States. In 1992, the Louisiana Department of Health and Hospitals (DHH) instituted 
a surveillance system for maternal deaths occurring up to 90 days from birth. This required 
that all death certificates within the state ask the question, “if deceased was female 10-49, 
was she pregnant within the last 90 days?” In 2010, the Maternal and Child Health Branch 
of DHH created the Louisiana Pregnancy-Associated Mortality Review (LaPAMR). This 
used death certificates and linked this information with hospital, autopsy and prenatal 
records. As well, it considered late maternal death, to within 365 days of a woman having 
given birth. The majority of deaths occurred 60-365 days after birth and were due to 
accidental injury and homicide. For the purposes of this study, these types are deaths are 
not considered. The majority of medically related causes of death were cardiovascular 
disease (47.1%); infection, pulmonary embolism and cancer tied for second most 
common.  
2.4 Calculating MMR–Queensland 
In Australia, the various states are responsible for maternal mortality calculations 
that inform nationwide statistics. Queensland is the focus of this study, and the 
Queensland Maternal and Perinatal Quality Council (QMPQC) is responsible for 
overseeing this process. A checkbox to indicate if a woman was less than or equal to 6 
weeks pregnant or if she was pregnant greater than 6 weeks to within 1 year of her death 
is on all Queensland death certificates (QMPQC, 2011). A maternal mortality death 
reporting form provides further detail. In all cases of death within 1 year of pregnancy, the 
QMPQC approaches the health care practitioner who was primarily involved with the 
patient. Response to these requests was noted to be highly variable in terms of detail and 
compliance (Humphrey, 2013). 
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2.4.1 Aboriginal and Torres Strait Islander women 
It is well recognized by the QMPQC that Aboriginal and/or Torres Strait Islander 
(ATSI) women have a higher frequency of maternal deaths than other minority groups in 
Australia. Of the 66 maternal deaths (including late maternal deaths between 43 and 365 
days of delivery) from 2009-2011, 15 were ATSI women. Issues surrounding maternal 
mortality in the ATSI are discussed in detail below.  
2.5 Comparing the United States and Australia  
The rationale behind comparing cohorts of women in the United States and 
Australia to determine the cause of increasing American MMR is three-fold: (1) Australia 
and the United States have similar levels of wealth, as measured by gross domestic 
product (GDP) per capita on purchasing power parity (PPP) (World Bank, 2016). They also 
have similar rates of medical comorbidities known to affect pregnancy, such as 
hypertension, diabetes and obesity (USA: WHO statistical profile, 2016) (Australia: WHO 
statistical profile, 2016). Furthermore, all Australian citizens and permanent residents are 
eligible for public health insurance under a socialised system, providing an interesting 
point of comparison to the United States’ health system during the study period. (2) 
America and Australia show divergent trends in MMR from 1995 onward. (3) An existing 
relationship is in place between the University of Queensland and Ochsner Clinic 
Foundation. Consequently, the aim of this study was to determine whether Americans and 
Australians have a similar rate of preventable maternal death and if the deaths were 
attributable to the same factors.  
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3. AIMS OF THESIS 
 The primary aim of this thesis is to explain the trend of increasing maternal mortality 
within the United States by comparing it with a country an antipodal trend, namely, 
Australia. This would be accomplished by comparing overall rates of preventable maternal 
mortality and what demographic factors could be significantly correlated to preventable 
maternal death.  
There is currently a paucity of research into the topic of maternal mortality in the 
Western world, as efforts are justly focussed on decreasing maternal mortality in 
developing countries. It is well recognised that reasons for maternal mortality are different 
between developed and developing countries, but very little research goes into elucidating 
disparities between Westernised countries.  
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4. OBJECTIVES 
4.a Primary objective 
The primary objective of this study is to compare rates of preventability of in-hospital 
maternal mortality between the OHS, which services a major portion of New 
Orleans, LA, and the QHS, the sole provider of public health care for the state of 
Queensland.  
4.b Secondary objective  
Secondary objectives are to assess if preventable deaths are secondary to 
provider-, systems- or patient-based failures of care or some combination thereof. 
These three categories are emphasised as they hold opportunities for intervention 
by medical personnel, hospital administration and policy-makers to yield positive 
impact to MMR. There are likely other levels of preventability, such as societal and 
personal, that are more difficult to define or target intervention.   
4.c Tertiary objectives  
Tertiary objectives are to compare the populations and try to establish 
commonalities that could account for why these women died while pregnant, during 
childbirth or in the 6 weeks postpartum.  
4.d Quaternary objective 
A quaternary objective for the American cohort is to calculate individual rates of 
overall and preventable MMR for various demographic characteristics of interest.  
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5. HYPOTHESES 
5.1 Primary hypotheses 
H0: Cases of maternal mortality within the OHS and QHS during the period 1995-
2013 have statistically similar rates of preventability.  
HA: Cases of maternal mortality within the OHS during the period 1995-2013 have a 
statistically significantly higher rate of preventability than those within the QHS. 2 
5.2 Secondary hypotheses 
H0: Cases of maternal death (both preventable and not preventable) within the OHS 
and QHS during the period 1995-2013 are attributable to similar causes.  
HA: Cases of maternal death (both preventable and not preventable) within the OHS 
and QHS during the period 1995-2013 are not attributable to similar causes.  
 
 
 
 
 
 
                                                
2 Hypothesis was adapted from Geller, Stacie E. et al. “The continuum of maternal 
morbidity and mortality: factors associated with severity” AJOG 2004 191, 939-44. Much 
like this study, a multidisciplinary team meeting (MDT) will determine preventability. “An 
event was considered preventable if it could have been avoided by any action or inaction 
on the part of the health care provider (eg, mismanagement of patients, failure or delay in 
diagnosis), the system (eg, failure in communication), or the patient (eg, noncompliance) 
that may have caused or contributed to progression to more severe morbidity or death… 
Preventability does not necessarily mean that the medical condition itself was preventable, 
but rather that a woman’s outcome might have been at a less severe point along the 
continuum were it not for the preventable event” (940-41). 
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6. STUDY DESIGN 
The design of this study was a retrospective cohort study (evidence level III). The 
exposure was being pregnant in the United States, which is known to have a higher 
mortality than pregnancy in Australia. The unexposed population, or comparison 
population, was the Australian cohort. The outcome was potentially preventable death. 
This was a suitable study design for the patient population in question: patients who died 
of identifiable obstetric causes while pregnant, while labouring or within 42 days of giving 
birth or termination of pregnancy. 
6.1 Ethical approval 
The study commenced in Brisbane at the Royal Brisbane and Women’s Hospital 
(RBWH), where initial institutional review board (IRB) approval was granted 
(HREC/14/QRBW/177). A waiver of consent was also issued through a Public Health Act 
(PHA) on the basis that it would be excessively onerous to attain consent from the next of 
kin of these maternal mortality cases (RD005216). The candidate also felt the data were 
de-identified to the point where any interested party reading a future publication would not 
be able to identify their loved one’s participation in the study.  
The initial design was to only include the RBWH and the Mater Mothers’ Hospital. 
Data collection difficulties at the latter site and a paucity of cases required the thesis 
candidate to approach the Queensland Health Statistics Branch (HSB) for access to all 
cases of maternal death within the state during the study period. A further PHA 
amendment allowed for the provision of codified data to the candidate (RD005614). The 
investigatory team did not feel the codified data were robust enough to undergo 
preventability classification by a multidisciplinary team (MDT) (methodology described 
below) and sought to conduct a chart review at as many of the sites identified by the HSB 
as possible. Of note, requirements for a site-specific application (SSA) varied from hospital 
to hospital. The candidate supplied an SSA where requested. These were Caboolture – 
Redcliffe (initially approached for inclusion but could not supply data in time for final MDT 
meeting) and the Mater.  
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Concurrently, ethical approval was gained in the OHS within the first year of the 
study. Approval here was based on RBWH IRB approval, the first time the OHS IRB has 
approved a project based on a foreign permission (2014.142). The OHS IRB, acting as a 
privacy board, issued a Health Insurance Portability and Accountability Act of 1996 (HIPAA) 
waiver for the study, allowing data access without informed consent. 
6.2 Data collection 
6.2.1 Data collection–Australia  
The HSB provided linkage data between the Queensland Perinatal Data Collection 
(QPDC) and death records and the Queensland Hospital Admitted Patient Data Collection 
(QHAPDC) and death records (PDC manual) (QHAPDC manual). Initial identification was 
based on ICD-9 and ICD-10 codes, as well as text search for the words “maternal,” 
“obstetric,” “pregnant,” “labour,” “puerperium,” and/or “placenta” in the cause of death field. 
The Queensland HSB was responsible for extracting patient charts that fit the inclusion 
criteria and ensuring patients weren’t counted twice.  
 Charts were accessed at all facilities identified by the HSB with more than 1 
instance of maternal death during the study period, where ethical approval was granted 
during the years that the study was ongoing, and where a research investigator was 
present. These conditions limited the geographic scope of the study to southeastern 
Queensland. (Fig. 3) 
The investigators were all University of Queensland Faculty of Medicine students, 
including the candidate (RBWH and Mater Mothers’ Hospital), Dr Ruby Chang (Ipswich 
Hospital and Brisbane environs and Dr Bennett Naprasnik (responsible for the Sunshine 
Coast region). The investigators reviewed 18 charts, and 15 were ultimately included. 
Three were excluded because cause of death was missing. In all 3 cases, a paucity of 
data prevented evaluation by the MDT. 
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6.2.2 Data collection–United States 
 Initially, 104 charts were identified by linking a diagnosis-related group (DRG) 
specific to pregnancy identified by ICD-9, ICD-10 and Current Procedural Technology 
(CPT) codes to a discharge code of deceased in the period January 1, 1995-December 
31, 2013. Patients were identified using multiple medical records systems, including Epic® 
electronic medical record and paper documents; outside facilities and practitioners were 
contacted when appropriate. Many more charts were identified in the OHS audit than from 
within the QHS because the initial survey identified deaths beyond the 42 days specified 
by the WHO criteria. This required the investigatory team to narrow these charts to those 
meeting the WHO criteria of maternal death (17 total). One chart was eliminated because 
Fig 3: Geographic reach of study.  
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the patient received obstetric care in the OHS but died outside of a hospital setting. (Fig. 4) 
The candidate or investigator located at each site reviewed each chart and formed 
a de-identified profile for each of the patients involved. This profile included their ethnicity, 
maternal age, all causes of death (including precipitating events), gravidity and parity, 
when diagnosis of pregnancy was made, number of prenatal appointments, complications 
of pregnancy, medications (including those stopped for pregnancy), past medical history 
(PMH), past surgical history (PSH), foetal presentation (cephalic, breech, transverse), 
number of foetuses, placental presentation, placental location method of delivery, body 
mass index (BMI), lifestyle factors, insurance status, gestation age at death/number of 
days postpartum at death, type of labour, interventions, birth attendant, classification of 
death, avoidable factors, termination of pregnancy, lowest haemoglobin, glucose screen, 
research studies mother was participating in, pain relief during labour and stillborn/live 
Fig 4: Data collection process. 
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birth. These characteristics were based on what was commonly recorded in the QHS 
maternity and death records, with additional demographic characteristics included in the 
data collection when it was felt appropriate by the candidate’s advisors (Appendix 1).  
6.3 Preventability classifications 
A literature search was conducted to determine the most widely accepted method 
for classifying preventability of maternal mortality. This search yielded support of the 
preventability classifications published by Dr Stacie Geller from the University of Illinois at 
Chicago. Not only were these preventability classifications specific to the population 
studied in this thesis (maternal deaths in Western countries), but they also had a strong 
interrater reliability (overall agreement 77%, Cohen’s kappa 0.49) (Geller, 2007). In 
accordance with Dr Geller’s previous publications on maternal mortality, members of the 
MDT were instructed to envision maternal mortality on a continuum from healthy 
pregnancy to minor morbidity to major morbidity to death. Women can enter the continuum 
at any point but, for the purposes of our study, they were united by the common endpoint 
of death. Further, Dr Geller defined an event as preventable “if it could have been avoided 
by any action or inaction on the part of the health care provider, the system, or the patient 
that may have caused or contributed to progression to more severe morbidity or 
death…[therefore] preventability does not necessarily mean that the medical condition 
itself was preventable, but rather that a woman’s outcome might have been at a less 
severe point along the continuum were it not for the preventable event” (Lawton, 2014). 
Dr Geller and her colleague Dr Jane MacDonald from the University of Otago, New 
Zealand, were contacted before the first MDT meeting to discuss the logistics for 
assembling the team. She generously provided the preventability forms used in previous 
studies. The final group was composed of 2 maternal-foetal medicine specialists, 2 
obstetrician/gynaecologists, 1 certified nurse-midwife, 2 obstetrics/gynaecology resident 
physicians, 1 labour and delivery charge nurse, 1 obstetrics anaesthesia staff member, 
and 1 obstetrics anaesthesia fellow. The first meeting, during which only the OHS data 
were classified, convened on Saturday August 15, 2015. The MDT received a tutorial on 
the study and method of classifying deaths and then reviewed each case and assigned 
preventability classifications. The meeting took place as a roundtable discussion, in which 
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the 10 members received a brief synopsis of each case, read the detailed patient profile 
for 10-15 minutes, discussed features that interested them or sought clarification, and then 
voted on the tasks listed below. The committee was required to discuss the cases until 
consensus was reached on the overall preventability category of each case. In a couple of 
instances, these discussions were drawn out, and determinations were difficult to make.  
With the Dr Geller’s definition in mind, team members were instructed to complete 3 tasks:  
1. To determine if a death was 
(a) preventable 
(b) potentially preventable with a definite improvement in care necessary  
(c) not preventable 
2. If the death was preventable or potentially preventable, to determine if there was 
(a) provider failure 
(b) system failure 
(c) patient failure  
(d) combination of above 
3. To assess whether the woman entered her pregnancy 
(a) in a healthy state 
(b) with minor morbidity  
(c) with major morbidity 
The MDT was asked to reach consensus on the first task and majority ruling on the 
latter two. Morbidity classifications were chosen by the MDT and were based on when the 
patient entered prenatal care.  
Factors that could contribute to preventable and potentially preventable deaths were 
divided into 12 groups categorized by provider-, patient-, and systems-related factors.  
1. Assessment/point of entry to care (provider)  
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a. Denial of access to care or appointment  
b. Failure to offer preventive treatment  
c. Delay in assessment/evaluation of patient  
d. Failure to get complete medical history  
2. Diagnosis/recognition of high risk (provider)  
a. Inappropriate diagnosis 
b. Delay 
i. In diagnosis/recognition of high-risk status 
ii. In ordering or checking laboratory tests 
iii. In recognition of abnormal vitals 
iv. In recognition of surgical complications 
c. Failure 
i. In diagnosis/recognition of high-risk status 
ii. In ordering or checking laboratory tests 
iii. In recognition of abnormal vitals  
iv. In recognition of surgical complications 
3. Refer to expert (provider) 
a. Delay in referral 
b. Failure to refer 
4. Treatment (provider) 
a. Delay in treatment  
b. Inappropriate treatment 
c. Failure to treat 
d. Inadequate / failure of equipment  
5. Treatment hierarchy (provider) 
a. Failure to check on junior’s work 
b. Failure to consult superior 
6. Education (provider) 
a. Lack of knowledge/training  
7. Communication (system) 
a. Between direct maternity providers 
b. Between other health practitioners and maternity providers 
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c. Between other health practitioners  
d. Between departments 
e. Between hospitals 
f. Between provider and patient  
g. Between other health practitioners and patient   
h. Chain of responsibility unclear 
i. Language difficulties  
8. Policies and procedures (system) 
a. Regarding laboratory results 
b. Regarding oversight (of residents, nurses, etc) 
c. Regarding scheduling and assessment  
d. Regarding emergency preparedness 
e. Regarding patient education  
f. Policies not followed  
g. Policies not in place 
9. Documentation (provider) 
a. Poor charting 
b. Failure to chart 
c. Poor legibility 
10. Discharge (provider) 
a. Inappropriate discharge 
b. Failure to counsel patient  
c. Failure to follow up 
11. Delay of systems 
a. Transport  
b. Laboratory  
c. Other 
12. Patient factors  
a. Failure to seek care 
b. Inadequate antenatal care 
c. Noncompliance with treatment  
d. Smoker (if related to outcome) 
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e. Alcohol abuse 
f. Other drug abuse 
g. Belief system  
h. Failure to use seat belt  
i. Violence 
j. Obesity  
k. Mental Health  
l. Other 
(Geller, 2006). (The preventability form is not included in the appendix of this thesis 
secondary to copyright permissions.) 
A second MDT meeting composed of the same members was conducted on 
Saturday March 19, 2016, to classify the QHS data. This meeting followed an identical 
methodology, with the exception that the introductory session on the preventability 
classifications was shortened because the group had received the information during the 
first MDT meeting.  
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7. STUDY SETTINGS  
Coordinating centres: Royal Brisbane and Women’s Hospital 
   Women’s and Newborn Services 
   Level 5  
   Ned Hanlon Building 
   Metro North Health Service District  
   Butterfield St  
   Herston, Queensland, Australia 4006 
 
   Ochsner Health System  
   1514 Jefferson Highway 
   New Orleans, Louisiana, USA 70121 
Other centres included:  
   Mater Health System (including Mater Mothers’ Private, Mater 
Hospital Brisbane and Mater Mothers’ Hospital) 
 
   Caloundra Hospital  
   West Terrace, Caloundra QLD 4551 
 
   Gympie Hospital  
   12 Henry St, Gympie QLD 4570 
   Ipswich Hospital  
   Chelmsford Ave, Ipswich QLD 4305 
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   Nambour Hospital  
   Hospital Rd, Nambour QLD 4560 
 
   Ipswich Hospital  
   Chelmsford Ave, Ipswich QLD 4305, Australia 
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8. STUDY DURATION 
The Gantt chart in Fig 5 shows how the study progressed during 46 months 
(September 2013-June 2017). 
Australian data collection and analysis significantly lagged behind American, 
secondary to the ethical approvals necessary at these hospitals.  
Red bars represent when research was being conducted concurrently in both 
countries. Blue bars represent when portions of American research had finished while 
Australian research continued.  
 
Fig 5: Gantt chart showing study progression.  
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9. STUDY POPULATION 
The study population included women of reproductive age from all racial, social, 
religious and cultural backgrounds who were inpatients at one of the study settings and 
were coded as having died from obstetric causes within the period January 1, 1995-
December 31, 2013. This makes the requirements to be selected for our study more strict 
than the ICD-10 definition of maternal death used by the WHO because it only includes 
inpatient deaths.  
 For the purposes of data analysis, 2 patient populations were formed. An American 
cohort was comprised of data collected at the OHS in New Orleans, LA. An Australian 
cohort was comprised of data collected from all hospitals listed in Section 7. The two 
cohorts are named so based on their country of origin, but it is not suggested that the 
findings within the OHS and QHS can be generalized to the American and Australian 
population at large, respectively. The Australian cohort was considered the unexposed 
group to which the American cohort was compared. The rationale for this terminology 
relates to regional differences in MMR during the years studied. Australian MMR mirrors 
that of most other Western countries. Characteristics of the study population in relation 
their the preventability of their maternal mortality are listed in Appendix 2 and 3. 
9.1 Inclusion criteria 
 Charts were collected for women who were inpatients at one of the study sites 
during the period January 1, 1995-December 31, 2013 (when the study began) and whose 
deaths could be classified as a maternal death according to the ICD-10 criteria of having 
died “while pregnant or within 42 days of termination of pregnancy, irrespective of the 
duration or site of the pregnancy, from any cause related to or aggravated by the 
pregnancy or its management but not from accidental causes.” (Trends in maternal 
mortality: 1990 to 2015, 2015). 
9.2 Exclusion criteria  
 Charts were excluded during the initial review if they lacked a cause of death. It was 
felt these cases were too vague to be rigorously classified by the MDT. It should be noted 
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that any chart with a cause of death was included, but detail in the cause of death field 
varied widely. Some cases had detailed autopsies, while others only had a couple of notes 
or a standard issue form filled out.  
9.3 Potential for risks, benefits and burdens 
 All patient information was de-identified and made non-re-identifiable so that 
patients’ relatives cannot identify their loved ones’ inclusion in this study. The candidate 
believes this reduces the potential for risks or burdens.  
 The potential for benefit of this study is to reduce the maternal mortality of the 
United States and curb its upward trend. Other potential benefits include further 
decreasing the MMR of Australia, decreasing the MMR of other Western counties, and 
contributing to the literature on best-practice guidelines for dealing with high-risk 
pregnancy.  
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10. DATA MANAGEMENT AND STORAGE  
All data came from hospital charts and were analysed on location; charts were 
collected by the heads of each team and did not leave the hospital from which they were 
collected. De-identified patient profiles were transferred to the primary investigators at the 
OHS. One Australian hospital required that all American investigators viewing their data 
have an appointment within The University of Queensland. All collected data were made 
non-re-identifiable. The project finished at the close of December 2016.  
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11. DATA MONITORING  
Patient profiles were regularly reviewed by the candidate’s advisors to ensure 
quality and that relevant data were being gathered.  
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12. SAMPLE SIZE AND DATA ANALYSIS  
12.1 Sample size and statistical power  
Maternal mortality is a rare event, especially in Western countries, and therefore the 
expected sample size was low. This decreases the power of this study; however, we 
accept this limitation because the study’s main purpose is the production of qualitative 
data. We anticipated sample size would be limited by the number of maternal deaths in the 
period 1995-2013, the number of charts available to us, and the number of locations from 
which we could access charts.  
12.2 Data analysis plan 
A statistician was consulted to select a statistical method for the study (t test, chi-
square, multivariate model, etc.) 
Summary statistics are presented as frequency (percentage) for categorical 
outcomes. Demographic characteristics were correlated to maternal death and 
preventability. The association between patient characteristics and cohort 
(American/Australian) and type of death (potentially preventable/not preventable) is 
examined using Fisher exact test. The association between clinical characteristics and 
cohort is reported using risk difference (RD) and 95% confidence intervals. RD was 
calculated by subtracting the Australian risk from the American risk; a positive RD favours 
the Australian cohort, and a negative one favours the American cohort.  
The American data were analysed in significantly more detail than the Australian 
data. MMR was calculated for various demographic characteristics in the American cohort. 
These were correlated to maternal death and preventability. Population-level data from the 
Louisiana Office of Public Health specific to the OHS was provided for the same 
demographic characteristics to calculate specific MMRs. Live birth numbers were used as 
the denominator and individual characteristics were used as the numerator in the 
calculated MMR. Incidence rate ratios (IRR) were computed by comparing the incidence 
rate of death (per 100,000 live births) between 2 populations. Poisson regression models 
were used to calculate MMRs and IRRs with 95% Wald-based confidence intervals. The 
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hope was to also perform these calculations with the Australian data. However, a number 
of cases had to be excluded because detailed cause of death information was not 
available to the investigators. Usually, this was due to a patient transfer to a hospital where 
the study was not permitted. Occasionally it was due to poor charting or intervention by a 
third party such as the legal counsel managing the case or state coroner. While live birth 
data for the state of Queensland were made available to us, due to these exclusions the 
candidate and his team did not feel we could reliably produce estimates of MMR for the 
Australian cohort.  
The association between patient characteristics and preventability status is reported 
as a relative risk (RR). RR was determined by comparing the percentage of potentially 
preventable deaths with a certain characteristic with not-preventable deaths with the same 
characteristic. Significance was calculated using Fisher exact test. A P value <0.05 was 
considered statistically significant. Statistical analysis was undertaken using Stata 
statistical software v13.1 (StataCorp, College Station, TX, USA). 
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13. GRAND DISCUSSION 
Because of the significant delay in collection of Australian data, data from this study 
were submitted as 2 separate publications (Appendix 4 and 5). The first takes an in-depth 
look at maternal mortality in Louisiana within the OHS. The second compares maternal 
mortality within the OHS to that of the QHS. The first paper, published in the International 
Journal of Gynaecology and Obstetrics, is the first paper, to the authors’ knowledge, that 
attempts to calculate individual MMRs for various demographic characteristics (eg, 
ethnicity, insurance status, number of prenatal appointments, etc) within a single hospital 
system.  
The second publication compared the American cohort to the cohort in Australia in 
an attempt to elucidate differences between the women that may have contributed to a 
higher MMR in the former. In this study, we did not calculate various MMRs. This was the 
initial plan and we were granted the population-level data to do so, but the investigatory 
team felt too many cases were potentially missing or excluded for the aforementioned 
reasons to do so accurately. Instead, we sought to determine if the same variables such 
as insurance accommodation and point of entry into prenatal care that were so important 
in the OHS played the same crucial role in determining the outcome of women within the 
QHS.  
13.1 Summary of main findings  
13.1.1 Summary of main findings–American cohort  
Within the American cohort, 4 (25%) deaths were deemed not preventable and 12 
(75%) were deemed potentially preventable. Of the 12 potentially preventable deaths, 9 
(75%) were linked with provider-based failures, 9 (75%) with systems-based failures, and 
6 (50%) with patient-based failures. The most commonly encountered provider-based 
failures were delays in assessment/evaluation of a patient (approximately 3 cases), delay 
or failure in diagnosis/recognition of high-risk status (approximately 6 cases), and delay in 
referral to an expert (approximately 5 cases). The most commonly encountered systems-
based failures were communication issues of all types (between providers, departments, 
hospitals and patients; approximately 9 cases). The most common patient-based failures 
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included failure to seek care or inadequate prenatal care (approximately 3 cases), and 
belief systems such as refusal of antibiotics, blood products or procedures (approximately 
2 cases). These numbers are estimates because the MDT was not asked to reach a 
consensus on what specific factors lead to a provider-, systems-, or patient-based failure. 
This was left to their individual discretion and was used as an aid to help them classify the 
deaths into the larger categories of provider-, systems-, or patient-based failure. 
Late entry into prenatal care—defined as first prenatal visit during or after 14 weeks 
of pregnancy—was associated with an increased risk of maternal mortality in terms of both 
overall maternal deaths and potentially preventable deaths. (Table 1 and 2; P=0.004 for 
both)  
 
 
 
Characteristic 
 
 
Cases 
 
 
Total live 
births 
Deaths per 100 000 live births 
(maternal mortality ratio) 
Incidence rate 
ratio (95% 
confidence 
interval) 
 
P valuea 
Ethnic originb      
White 9 21 575 41.7 1.0 – 
Black 6 19 218 31.2 0.8 (0.3–2.1) 0.616 
Transfer from outside facility 
No 12 44 599 26.9 1.0 – 
Yes 4 937 426.9 15.8 (5.1–48.9) <0.001 
Insurancec     
Private 0 5208 0.0 – – 
Medicaid 6 10 295 58.3 1.0 – 
Uninsured 2 249 803.2 13.8 (2.8–67.9) 0.014 
Age, y      
≤24 4 15 772 25.4 0.6 (0.2–1.9) 0.430 
25–34 10 23 774 42.1 1.0 – 
≥35 2 6044 33.1 0.8 (0.2–3.6) >0.99 
Entry into prenatal cared      
1st trimester (routine) 5 37 560 13.3 1.0 – 
Late or none 6 7147 84.0 6.3 (1.9–20.6) 0.004 
Parity 
Nulliparous 3 19 018 15.8 1.0 – 
Multiparous 13 29 627 43.9 2.8 (0.8–9.8) 0.125 
aRefers to incidence rate ratio. 
bUnknown for one case. 
cInsurance data available from December 6, 2010, onwards. 
dData not available for five cases. 
Table 1: Associations between characteristics and maternal mortality (n=16). 
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With regard to insurance accommodation, 5 (31%) patients in the present study had 
private insurance, 9 (56%) had Medicaid and 2 (13%) were uninsured. Mandatory 
reporting of insurance data on the birth certificate at the state level began in December 
2010; therefore, analyses of MMR for the OHS included only the 8 maternal deaths (6 
Medicaid and 2 uninsured) that occurred from this point onwards. (Table 1) Separate 
analyses not related to MMR calculations for the OHS include all 16 deaths.  
All the not-preventable deaths occurred in the population with private insurance. All 
deaths in the Medicaid and uninsured populations and 1 in the population with private 
insurance were considered potentially preventable. The fact that 8 of the 16 cases were 
from the last 3 years of the 18-year study period indicates that the national trend of 
increasing maternal deaths is reflected in the study population. 
The calculated MMR for Medicaid patients was 58.3 overall and for potentially 
preventable deaths (Tables 1 and 2). The uninsured population yielded the most 
significant MMR. A significant association was found for the IRR of maternal death in an 
uninsured patient when compared with a Medicaid patient (P=0.014) (Tables 1 and 2). 
When comparing not-preventable and potentially preventable deaths within the OHS itself 
(i.e. excluding population level data), a significant association between preventability and 
specific demographic characteristics was found only for private insurance accommodation 
(P=0.003) (Table 3). 
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Characteristic 
 
 
Cases 
 
 
Total live births 
Deaths per 100 000 live births 
(maternal mortality ratio) 
Incidence rate ratio (95% 
confidence interval) 
 
P valuea 
Ethnic origin      
White 6 21 575 27.8 1.0 – 
Black 6 19 218 31.2 1.1 (0.4–3.5) >0.99 
   Transfer from outside facility  
No 9 44 599 20.2 1.0 – 
Yes 3 937 320.2 15.8 (4.2–58.3) 0.002 
Insuranceb    
Private 0 5208 0.0 – – 
Medicaid 6 10 295 58.3 1.0 – 
Uninsured 2 249 803.2 13.8 (2.8–67.9) 0.014 
Age, y      
≤24 3 15 772 19.0 0.6 (0.2–2.5) 0.749 
25–34 7 23 774 29.4 1.0 – 
≥35 2 6044 33.1 1.1 (0.2–5.4) >0.99 
Entry into prenatal carec      
1st trimester (routine) 3 37560 8.0 1.0 – 
Late or none 5 7147 70.0 8.8 (2.1–36.6) 0.004 
   Parity  
Nulliparous 2 19 018 10.5 1.0 – 
Multiparous 10 29 627 33.8 3.2 (0.7–14.6) 0.144 
aRefers to incidence rate ratio. 
bInsurance data available from December 6, 2010, onwards; incidence rate ratios not calculated. 
cData not available for four cases 
. 
Table 2: Associations between characteristics and potentially preventable maternal mortality 
(n=12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Factor 
 
 
Not preventable (n=4) 
Potentially 
preventable (n=12) 
Relative risk (95% 
confidence interval) 
 
P value 
Major morbidity 3 (75) 7 (58) 0.8 (0.4–1.6) >0.99 
Black ethnic originb 0 6 (50) – 0.229 
Private insurance 4 (100) 1 (8) 0.1 (0.0–0.5) 0.003 
Obstetrician attending birth 2 (50) 3 (25) 0.5 (0.1–2.0) 0.547 
Transferred from outside facility 1 (25) 3 (25) 1.0 (0.1–7.1) >0.99 
Transferred to higher level of care 0 2 (17) – >0.99 
Delivery within Ochsner Health System 3 (75) 7 (58) 0.8 (0.4–1.6) >0.99 
Late or no prenatal carec 1 (33) 5 (63) 1.9 (0.4–10.1) 0.545 
Multiparous 3 (75) 10 (83) 1.1 (0.6–2.1) >0.99 
aValues are given as number (percentage) unless indicated otherwise. 
bUnknown for one unpreventable case. 
cEntry into prenatal care unknown for one not preventable case and four potentially preventable cases. 
Table 3: Association between factors affecting maternal mortality and preventability.a 
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Initially the candidate attempted to correlate these findings to changes in Louisiana 
Medicaid funding during the study duration. Table 4 appeared in the rough draft of the first 
paper submitted for publication; they were excluded from the final draft because it was felt 
that not enough evidence existed in the data to draw such drastic conclusions. Still, the 
correlation between maternal outcomes and state funding for public insurance programs is 
an interesting area for future research. If nothing else, these preliminary findings 
underscore the importance of funding public health care in the United States. 
The largest concentration of deaths, especially potentially preventable deaths, 
occurred amongst patients with Medicaid. This realization prompted analysis of the 
benefits provided under the Medicaid program for each year of our study. Prior to January 
2003, emergency Medicaid was available to pregnant women whose income was ≤133% 
of the federal poverty guidelines (FPG). After 2003, with the introduction of the Louisiana 
Medicaid for pregnant women (LaMOMS) program, women who became pregnant and 
had incomes up to 200% of the FPG were allowed coverage. Coverage allowed for 
prenatal care for each month of pregnancy and up to 2 months postpartum. The total 
number of recipients and the amount of funding is mandatorily reported for each year that 
LaMOMS has been in existence (Bhaskar, 2013). While a greater proportion of the 
population gained access to emergency Medicaid under the LaMOMS program, funding 
discrepancies still exist from year to year (Table 4). Interestingly, the highest number of 
both total deaths and potentially preventable deaths in patients insured with Medicaid 
occurred in 2010-2012 (77.8%, n=7) when LaMOMS received the least amount of funding 
per capita since reporting began in 2005-2006. We don’t claim causality suggested by 
these numbers, but consideration must be paid to these numbers because they 
underscore the necessity of providing funding to the LaMOMS program and to statewide 
funding of emergency Medicaid for pregnant women. 
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State Fiscal Year (SFY) 
 
Number of women insured Total LaMOMs funding 
(USD) 
Total LaMOMs funding 
/ # of women insured 
(USD / person) 
2002 / 03 49,000* N/A N/A 
2004 / 05 53,701 N/A N/A 
2005 / 06 69,897 206,585,136 2956 
2006 / 07 71,960 226,881,883 3152 
2007 / 08 69,769 238,321,794 3415 
2008 / 09 73,996 252,965,316 3418 
2009 / 10 68,517 245,555,900 3583 
2010 / 11 82, 052 209,807,857 2557 
2011 / 12 70,096 208,078,631 2968 
2012 / 13 73,369 244,815,774 3336 
*Approximate for 2002-2003 year.  
Table 4: Funding for LaMOMs during each year in existence.  
 
 Five of the 16 patients at OHS who died had been transferred within or to the OHS 
at some stage of their care because of a requirement for a higher level of care (Fig 6). 
Patients who transferred to OHS had an MMR of 426.9 and 320.2 in the overall and 
potentially preventable maternal death categories, respectively (Tables 1 and 2). The IRR 
of maternal death in a patient transferred was 15.8 overall and in the potentially 
preventable category. Three-quarters of the potentially preventable deaths after transfer 
were linked with provider- and systems-based failures before their transfer (Fig 6). 
 
13.1.2 Summary of main findings–cohort comparison 
We compared the American cohort to an Australian cohort populated by women 
who used QHS and the Mater Mother’s Hospital as their main source of obstetric care in 
our second publication. Table 5 shows that there were no statistically significant 
differences in characteristics between the cohorts, although there was a trend for 
Australian women to be older (mean=32.5 years vs 28.8 years, P=0.14) and less likely to 
have private insurance (6.7% vs 31.3%, P=0.17).  
Seventy-five percent of American deaths (n=12) and 73.3% of Australian deaths 
(n=11) were deemed potentially preventable. Of the American deaths, 3 (75.0%) of the 
patients with not-preventable deaths and 7 (58.3%) of the patients with potentially 
preventable deaths entered their pregnancies with major morbidity (RD=16.7%, 95%CI=-
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34.1%, 67.4%; P=1.00). Of the Australian deaths, 2 (66.7%) of the patients with not-
preventable deaths and 5 (45.5%) of the patients with potentially preventable deaths 
entered their pregnancies with major morbidity (RD=21.2%, 95%CI=-39.7%, 82.1%; 
P=0.71). There was no statistically significant risk difference for preventable death 
between Australian or American woman entering their pregnancies with major morbidity 
(RD=12.9%, 95%CI=-27.7%, 53.4%; P=0.54). 
The MDT classified potentially preventable deaths as provider-based, systems-
based and/or patient-based deficiencies. Nine (75.0%) of the potentially preventable 
American deaths were thought to be complicated by provider-based failures of care, 9 
(75.0%) by systems-based failures and 6 (50.0%) by patient-based failures. Of the 
potentially preventable Australian deaths, 8 (72.7%) were thought to be complicated by 
provider-based failures of care, 6 (54.5%) by systems-based failures and 7 (63.6%) by 
patient-based failures.  
 
 
Fig 6: Transfers to the Ochsner Health System.  
a One transferred within the Ochsner Health System.  
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American cohort (n=16) Australian cohort (n=15) P-value 
Age, mean (range) 28.8 (19-37) 32.5 (23-41) 0.14 
Caucasian, n (%) 9 (56.3) 7 (46.7) 0.43 
BMIa, mean (range) 30.6 (16.1 – 54.9) 26.4 (18.7 – 35.0) 0.57 
Lifestyle factors complicating 
pregnancy, n (%)b 
6 (42.8) 3 (23.1) 0.25 
Entering with healthy pregnancy, n 
(%) 
2 (12.5) 1 (6.7) 1.00 
Entering with minor morbidity, n (%) 4 (25.0) 6 (40.0) 0.46 
Entering with major morbidity, n (%) 10 (62.5) 7 (50.0)c 0.48 
Primigravida, n (%) 3 (18.8) 1 (6.7)c 0.60 
Private insurance, n (%) 5 (31.3) 1 (6.7) 0.17 
Received general anesthesia, n 
(%) 
5 (31.3) 8 (53.3) 0.29 
Transferred at some point in care 
d, n (%) 
5 (31.3) 3 (20.0%) 0.69 
Continuous characteristics presented as mean (standard deviation) and categorical characteristics presented as frequency 
(percentage). 
a BMI at death. Not available for 2 American cases and for 6 Australian cases.  
bAny alcohol, tobacco or illicit drug consumption during pregnancy. Doesn’t include previous use. Not available for 2 American and 2 
Australian cases.  
c Not available for 1 case.  
d Between facilities. Does not include ICU admission.  
 
Table 5: Baseline characteristics of the American and Australian cohorts. 
 
 
Looking at the 2 cohorts separately, preventability of Australian maternal mortality could 
not be significantly linked to any demographic qualifier (Table 6). In the American cohort, 
however, private insurance accommodation is less correlated with preventable maternal 
mortality (P=0.003) (Table 7). 
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 Not Preventable, n=4 (%) Potentially preventable, n=11 (%) P-value 
Major Morbidity 2 (66.7%)a  5 (45.5%) 0.71 
 Non-white Ethnicity 1 (25.0%) 6 (60.0%)a  0.56 
 
Age ≥35 years  3 (75.0%) 3 (27.3%) 0.30 
Private Insurance 0 (0%) 1 (9.1%) 1.00 
Transferred during care  0 (0%) 3 (27.3%) 1.00 
 
Late or no prenatal care b 0 (0%) 1 (12.5%) 1.00 
Multiparous c 3 (100.0%)b 10 (90.9%) 1.00 
 
a Not known for 1 death. 
b Not known for 2 non-preventable deaths and 3 potentially preventable deaths.  
Table 6: Association between patient characteristics and preventability of maternal death: 
Australian cohort. 
 
 
 
 
 
 
Not Preventable, n=4 (%) Potentially preventable, n=12 (%) P-value 
Major Morbidity 3 (75.0%) 7 (58.3%) 1.00 
 Non-white Ethnicity 0 (0%) a 6 (50.0%) 0.23 
 
Age ≥35 years  0 (0%) 2 (16.7%) 0.73 
Private Insurance 4 (100.0%) 1 (8.3%) 0.003 
Transferred during care  1 (25.0%) 4 (33.0%) 0.82 
Late or no prenatal care b 1 (33.0%)  5 (62.5%) 0.55 
Multiparous c 3 (75.0%)  10 (83.3%) 1.00 
 
a Ethnicity not recorded for 1 patient.  
b Entry into prenatal care not known for 1 not preventable patient and 4 potentially preventable patients.  
c 3 Nulliparous patients included in study. 
Table 7: Association between patient characteristics and preventability of maternal death: 
American cohort. 
 
 
 
Comparing the 2 cohorts, late point of entry into prenatal care–defined as after 14 
weeks of pregnancy–or no prenatal care was correlated with a higher risk of overall death 
(RD=44.5%, 95%CI=9.7%, 79.4%, P=0.03) and potentially preventable death (RD=50.0%, 
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95%CI=9.3%, 90.6%, P=0.04) in the American cohort compared to the Australian cohort 
(Tables 8 and 9). No other factors reached statistical significance.  
 
 
 
 
USA, n=16 (%) 
 
 
AUSTRALIA, n=15 (%) Risk difference (95% CI); P 
Major Morbidity  10 (62.5%) 7 (50.0%) a 12.5% (-22.8%, 47.8%); 0.49 
Non-white 6 (40.0%) a 7 (50.0%) a -10.0% (-46.1%, 26.1%); 0.59 
Age>35 2 (12.5%) 6 (40.0%) -27.5% (-57.1%, 2.1%); 0.08 
Private insurance 5 (31.3%) 1 (6.7%) 24.6% (-1.4%, 50.6%); 0.08 
Public insurance / Medicaid  9 (56.3%) 12 (85.7%) a -29.5% (-59.9%, 1.0%); 0.08 
Transfer during care 5 (31.3%)% 3 (20.0%) 11.3% (-19.2%, 41.7%); 0.47 
Late /no prenatal care 6 (54.5%)b 1 (10.0%)b 44.5% (9.7%, 79.4%); 0.03 
Multiparous 13 (81.3%) 13 (92.9%)a -11.6% (-35.0%, 11.8%); 0.35 
a Not available for 1 case.  
b Not available for 5 cases.  
Table 8: Association between clinical characteristics and cohort for American and 
Australian maternal deaths: all cases. 
 
 
 
 
 
USA, n=12 (%) 
 (%) 
AUSTRALIA, n=11 
n (%) 
Risk difference (95% CI); P 
Major Morbidity  7 (58.3%) 5 (45.5%) 12.9% (-27.7%, 53.4%); 0.54 
Non-white 6 (50.0%) 6a (60.0%)
  
-10.0% (-51.5%, 31.5%); 0.64 
Age>35 2 (16.7%) 3 (27.3%) -10.6% (-44.3%, 23.1%); 0.54 
Private insurance 1 (8.3%) 1 (9.1%) -0.8% (-23.8%, 22.3%); 0.95 
Public insurance / Medicaid  9 (75.0%) 9 (81.8%) -6.8% (-40.3%, 26.6%); 0.69 
Transfer during care 4 (33.3%) 3 (27.3%) 6.1% (-31.4%, 43.5%); 0.75 
Late /no prenatal care 5b (62.5%) 1c (12.5%) 50.0% (9.3%, 90.6%); 0.04 
Multiparous 10(83.3%) 10 (90.9%) -7.6% (-34.7%, 19.5%); 0.59 
 
a Not available for 1 case.  
b Not available for 4 cases.  
c Not available for 3 cases.  
d Not available for 2 cases.  
Table 9: Association between clinical characteristics and cohort for American and 
Australian maternal deaths: preventable cases. 
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13.2 Implications  
 
13.2.1 Implications–American cohort  
In the OHS, Medicaid insurance, late entry into prenatal care and transfer from an 
outside facility were shown to be associated with maternal mortality within the OHS. These 
associations were also present when only potentially preventable deaths were considered. 
The only factor found to be specifically associated with preventability was private 
insurance. Provider- and systems-based failures were common amongst potentially 
preventable deaths that occurred after transfer to the OHS. 
The vast majority of maternal deaths—especially those that were potentially 
preventable—occurred amongst patients with Medicaid and without any insurance. Private 
insurance was inversely correlated with risk of preventable death, and MMR increased 
substantially from private insurance to Medicaid to uninsured status. (Table 2) The 2 
patients who had no insurance entered pregnancy in a state of major morbidity, and both 
deaths were considered potentially preventable, with adverse events occurring at the time 
of delivery. Neither patient had a documented visit with a high-risk specialist, despite their 
documented comorbidities. Insurance accommodation is linked with a woman’s ability to 
seek prenatal care. Closer monitoring of a high-risk pregnancy might have been achieved 
had these uninsured patients acquired Medicaid during their pregnancy. 
This study also stresses the importance of having a low threshold to transfer 
critically ill patients to a tertiary care centre early in the course of their illness. All the 
patients whose deaths after transfer to the OHS were classified as potentially preventable 
(n=3) were transferred with either anoxic brain injury in a comatose state or with 
multiorgan failure. Patients who are deemed sick enough for transfer are probably already 
critically or lethally ill by the time they receive care at a higher level care centre. It is 
paramount to have a low threshold to transfer high-risk obstetric patients to tertiary 
centres, where specialized consultant care and state-of-the-art technology can improve a 
patient’s course and outcome. 
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13.2.2 Implications–Comparing the OHS and QHS  
Because of the large catchment area of each hospital system, it is our impression 
that the cohorts in this study reflect larger trends in national maternal mortality. The 
American cohort data in this study mirror national mortality trends, with a majority of cases 
clustered in the later years of the study period. The Australian cohort data reach peak 
incidence in 2004 and then taper off, whereas Australian national data show a peak in 
2000 and then a downward trend (WHO, 2015). The relatively small sample size may have 
limited this study and its generalizability. The strengths of this study, however, are the 
rigorous method of case identification used in each country and the thorough account of a 
woman’s path that was presented to a highly trained MDT.  
A statistically significant number of American deaths, both preventable and overall, 
were linked to a late point of entry into prenatal care. Numerous factors affect a woman’s 
decision to seek prenatal care, including insurance status, patient education, 
socioeconomic status (SES) and time when the pregnancy is first confirmed. Our study 
found that amongst the American cohort, deaths in the group with private insurance were 
likely to be not preventable. In fact, 100% of the not-preventable American deaths were in 
the private insurance category, and only 1 of the 12 patients with potentially preventable 
deaths had private insurance. Conversely, all deaths in the Medicaid and uninsured 
categories were considered potentially preventable. As a point of reference, from 2010–
when insurance data become available at a statewide level–to 2013–when this study 
commenced–33.0% of maternity patients in the OHS had private insurance, 65.4% had 
Medicaid and 1.6% had no insurance according to data made available to us by the State 
of Louisiana Office of Public Health. 
The same trends did not hold true in the Australian cohort. Australian maternal 
mortality could not be statistically correlated to any of the demographic factors assessed 
indicating deaths in this cohort are more likely to be random occurrences. The authors 
arrived at the conclusion that although they face similar comorbidities in their home 
countries, pregnant women and new mothers in Australia and America encounter different 
barriers in access to health care. Anecdotal evidence would suggest that Australian 
hospitals serve a more remote population. However, with respect to population to hospital 
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ratio (measured as hospital beds per 1,000 persons) Australia leads the USA at 3.9 to 2.9. 
(Worldbank, 2016). Interestingly, the American cohort was 40% African-American (6 of 15, 
with one case of unrecorded ethnicity) and 60% Caucasian (9 of 15), whereas the 
Australian cohort was 46.7% Caucasian (7 of 15, with one case of unrecorded ethnicity) 
and the other 53.3% was a mix of Middle-Eastern, Aboriginal Australian, Asian and 
African. 
 
Finally, Australian Medicare is a publicly funded universal health care system. It 
allows the holder–an Australian citizen or permanent resident–a subsidised rate from 
practitioners who hold a Medicare number and provide free care in public hospitals. 
Private insurance also exists and allows the holder access to a wider range of services or 
care. Of the Australian hospitals surveyed, public insurance accommodation was vastly 
more common amongst maternity patients; the majority of hospitals had 5% or less of 
patients with private insurance during the study period. The American healthcare system 
during the years of our study (i.e. before the implementation of the Affordable Care Act) 
did not require Americans to hold an employer-sponsored health plan, Medicaid, Medicare 
or other public insurance program. The Affordable Care Act mandated this otherwise the 
uninsured person risked a penalty. (Obamacare Facts, 2015) 
Rates of access to prenatal care, in both the not-preventable and potentially 
preventable categories, were much lower in the American cohort than the Australian. The 
authors believe this may represent financial barriers to care existing in the American 
system that are not inherent in the Australian system. 
The events leading to a maternal death can be conceptualised as predisposing and 
precipitating factors. Predisposing factors are those that place a woman at a more high-
risk point on the maternal mortality continuum, while precipitating factors are those that 
accelerate her trajectory to ultimate mortality. The largest disparity between our two 
cohorts with regards to maternal health seems to be in predisposing factors such as 
insurance accommodation and access to prenatal care, that affect the course of a 
woman’s pregnancy before delivery. Census data indicate that the USA is still failing to 
achieve UN MDG 5A–a 75% reduction in its MMR. But, equally importantly, this study 
 46 
suggests the United States are not meeting goal 5B–universal access to reproductive 
health care–either.  
13.3 Strengths  
 The aims of this project were met, but on a smaller scale than what the candidate 
had originally conceived. We found a reasonable explanation for the high and increasing 
MMR within the OHS, but it is difficult to know if these findings can be extrapolated to the 
larger state or country as a whole. The lack of significant findings within the QHS further 
underscores the likelihood that maternal deaths in this cohort were more likely due to 
random chance than to a defect within the health care system. It is reasonable to postulate 
that even in countries with the safest maternity care, a certain number of maternal deaths 
will occur due to chance.  
 The authors feel that three of the four objectives were met.  The rates of 
preventability were shown to be comparable between the OHS and QHS. Secondly, 
similar rates of provider-based failures of care were demonstrated between the two health 
systems; however,  a higher rate of systems-based failures occurred in the OHS and a 
higher rate of patient-based failures occurred in the QHS. The third objective – 
establishing commonalities between women in the two cohorts – was not met. Although 
there were no statistically significant differences in baseline characteristics of the cohorts, 
cause of death and contributing factors were so varied that it was difficult to draw 
generalizations. (Table 5) The fourth objective – calculating MMRs for various 
demographic characteristics in the American cohort – was met and is presented in Tables 
1 and 2.  
13.4 Limitations  
The major limitation in both cohorts is the sample size. Because of the statistical 
rarity of maternal mortality in high-income countries, it is difficult to establish any specific 
causality, despite the trend toward increasing MMR in the United States. Additionally, the 
results would have been greatly affected if even one eligible chart had been missed. Once 
a patient had a pregnancy-related diagnosis, it would have been retained in her electronic 
medical record and would have been identified by coders in the study if she was also 
 47 
designated as deceased; however, a patient early in her pregnancy without any 
pregnancy-related codes, a miscoded patient, or a patient not designated as deceased 
could have been missed. 
The other limitation is in the inability to generalize about cause of death amongst 
the cohorts. In the United States, cardiovascular conditions are the most common reason 
for pregnancy-related mortality, followed by infection, noncardiovascular medical 
conditions, cardiomyopathy, haemorrhage, venous thromboembolism, and hypertensive 
disorders of pregnancy for the years 1998-2010 (Creanga et al., 2015) (Fig 7). In 
Queensland, thromboembolism, amniotic fluid embolism (AFE), haemolysis, elevated liver 
enzymes, low platelet count (HELLP) syndrome, and sepsis secondary to acute 
cholestasis were all tied as leading causes for direct maternal deaths within 42 days of 
delivery. In Queensland, suicide continues to be the leading indirect cause of death in 
within 42 days of delivery, followed by cerebrovascular causes of death (Humphrey et al., 
2013).  
In our study, there was a unique cause of death for nearly each patient studied. 
However, certain trends did prevail. In the American cohort, cardiac arrest was the most 
common cause of death, followed by brain injury and a pre-existing medical condition. In 
the Australian cohort, haemorrage and a pre-existing medical condition tied for the most 
Fig 7: Cause-specific proportionate pregnancy-related mortality: United States, 1987–2010.  
Creanga. Pregnancy-Related Mortality in the United States. Obstet Gynecol 2015.  
Reprinted with permission from Creanga et al., 2015. 
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common causes of death, followed by venous thromboembolism and cardiac arrest.  
13.4.1 Limitations–American cohort  
 There is certain homogeneity in the American arm of this study likely due to the 
small sample size. One example of this is the ethnic diversity–or lack thereof–of this 
cohort. 40% of the cohort was African American and another 60% was Caucasian. Other 
racial minorities were not represented at all. It has been well demonstrated in the United 
States that pregnancy-related mortality is highest amongst the African American 
population (Creanga et al., 2015). There are a couple of possibilities for why our study did 
not reflect this trend; the sample size likely was too small to detect a trend or the 
catchment area has a unique pregnancy-related mortality that does not reflect national 
trends. 
To our knowledge, this study is the first to extrapolate maternal mortality data for an 
individual hospital system and for various demographic characteristics. A prior study 
conducted by Geller et al. used the same definition of preventability to look at 610 
maternal deaths within the US state of Illinois in 2002-2012 (Geller, 2014). The Geller 
study had some parallels with the present one. First, Medicaid was cited as the source of 
insurance for most patients who died. Second, similar preventable factors were identified, 
such as failure to identify the patient as high risk (provider-based) and noncompliance with 
treatment (patient-based). According to Callahan, the prevention of maternal deaths will 
probably require provider adherence to best-practice measures and systems-based 
improvements in defining maternal early-warning criteria and conducting preventability 
reviews when an adverse event occurs (Callahan, 2014).  
Although the small sample size of the present study certainly brings its own 
challenges when drawing conclusions, the findings should encourage hospital systems to 
critically analyse current practices to predict and prevent poor maternal outcomes. Within 
the OHS, the preventability form used in the present study is now being used in real time, 
rather than retrospectively, to analyse adverse maternal outcomes and near-miss events. 
Hopefully, the present investigation will create a foundation for other hospital systems to 
use when creating their own maternal mortality review process.  
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13.4.2 Limitations–Australian cohort  
By adding the QHS to our data analysis, we attempted to increase the overall 
sample size of the cohort studied. However, because of the comparative nature of the 
study and the differences in the American and Australian populations, it wasn’t appropriate 
to analyse the 2 groups together. Therefore, analysis within the QHS suffered from the 
same limitations in sample size as did the OHS. As well, individual MMRs were not 
calculated for the Australian group due to the aforementioned issues with data reliability. 
Namely, that too many cases were excluded to accurately calculated the maternal deaths 
numerator in the MMR ratio. 
13.5 Future directions  
13.5.1 Future directions in the United States 
While estimates of MMR in the United States may be amended in the following 
years, as they were during the course of this study, the fact still remains that maternal 
mortality is on the rise. The findings of this study do not attempt to discount the importance 
of the medical team in reducing maternal mortality for their patients; rather, this study 
highlights the importance of how health system infrastructure affects the survival of its 
patients.  
There is no doubt that the United States is in a tumultuous period. The architecture 
of its health system is being dismantled and refigured. Millions of Americans who were 
afforded insurance under the ACA may need to seek new payers for their health care. It is 
similarly unclear how much of the population will be covered under Medicaid and what 
demarcation states will use on the FPL to determine who qualifies for coverage.  
On a more micro scale, the state of Louisiana saw great change politically during 
the years of the study. Governor Bobby Jindal (R–Louisiana), who did not use state 
funding to pay for the gap in Medicaid funding that wasn’t covered at a federal level, was 
replaced by Governor John Bel Edwards (D–Louisiana) who provided this funding. While 
our study detected a trend of increasing mortality in the years with the least funding, this 
could not be proven by the numbers surveyed.  
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If the newly elected President Donald Trump reforms the ACA in line with his 
campaign promises, many Americans who gained coverage in the years 2008-2016 will 
likely lose it and be forced to find private insurance or go uninsured. As this study 
demonstrates, uninsured women have demonstrably the worst outcomes with respect to 
both preventable and overall maternal mortality. The coming years will be crucial for 
providers to advocate for their patients and their patients’ rights to insurance coverage. 
Within Louisiana, the candidate suggests that providers make their low-income patients 
aware of the LaMOMS program. It will also become increasingly important that providers 
find solutions so these patients are able to obtain prenatal care early in their pregnancies.  
13.5.2 Future directions in Australia 
While Australia has a commendable MMR, it still falls short of the MMRs in 
Scandinavia and continental Europe. The cause is likely multifactorial. There is no doubt 
that Australia’s large refugee, immigrant and Aboriginal populations impact this number. 
The Australian cohort was 46.7% Caucasian (7 of 15, with one case of unrecorded 
ethnicity) and the other 53.3% was a mix of Middle-Eastern, Aboriginal Australian, Asian 
and African. This is not reflective of the demographic mix of the island country, in which 
approximately 74.3% of the population is Caucasian, 25.2% is other/unspecified (CIA 
World Factbook, 2016) and 2.8% is Aboriginal and/or Torres Strait Islander (Australian 
Bureau of Statistics, 2016). Reduction in MMR will likely only be achieved in Australia 
when inequalities in health care delivery to these populations are reduced. Similarly to the 
United States, this will likely require promoting early access to prenatal care amongst 
immigrant, Aboriginal and lower SES groups.  
Another avenue of potentially reducing Australian MMR is to target provider-and 
systems-based failures of care. American doctors Clark and Hankins identified 10 “clinical 
diamonds” to reduce maternal deaths (Clark, 2012). Four of these 10 diamonds involve 
imaging, specialist consultation or transfer. Economic pressures in this socialised system 
of medicine can precipitate hesitation amongst providers to pursue imaging or specialist 
treatment routes. As well, the pastoral nature of Australia puts many pregnant women far 
from metropolitan centres that offer speciality imaging or high-risk obstetrics specialists.  
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Finally, as mentioned in the introductory section to this thesis, the CEMACH has 
highlighted the importance of maternal early-warning systems in identifying and triaging 
patients who may become high risk during the course of their pregnancy (Clark, 2009). 
Delays in recognition, diagnosis and treatment precede a majority of deaths caused by 
haemorrhage, thromoboembolism, infection and hypertension, according to one American 
study (Myhre et al., 2014). In our study, Australians suffered from similar types of provider-
based failures of care.  
13.5.3 Future directions worldwide  
A discussion about maternal mortality wouldn’t be complete without talking about 
worldwide progress toward the fifth MDG. Worldwide, a 45% reduction in MMR was 
achieved between 1990 and 2015 (Fig 8). The greatest progress was seen in Southern 
and Eastern Asia. Sub-Saharan Africa still has the greatest MMR worldwide, although the 
region’s MMR decreased 49% in these 25 years.  
The greatest progress in maternal care worldwide was seen in the number of births 
attended by skilled personnel (from 59% to 71%), but this is highly concentrated in urban 
areas (87%) compared to rural areas (56%) in developing countries.  
Goal 5B–the universal provision of reproductive health care–is also far from being 
met. Currently, only about half of pregnant women are receiving the minimum 
recommended 4 antenatal visits. The need for increased contraceptive prevalence and 
family planning remains an issue worldwide. Increased contraceptive use contributes to 
decreasing unwanted pregnancy, unsafe abortions and maternal deaths. The largest 
disparity exists in Latin America, Sub-Saharan Africa and the Caribbean, where social 
norms and economic pressures play a role. 
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Fig 8: Southern Asia and Eastern Asia have made the 
greatest progress in reducing maternal mortality. 
Reprinted with permission from Way et al., 2015.  
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Finally, there is a worldwide need for better collection of maternal death data. 
Currently, only 51% of countries reliably report cause of death in instances of maternal 
mortality.  
The UN has transitioned the MDGs into Sustainable Development Goals (SDGs) for 
the coming decade and a half. SDG 3 aims to reduce the global MMR to less than 70 
maternal deaths per 100,000 live births by 2030. It also builds on UN MDG 5B by aiming to 
achieve universal access to sexual and reproductive health care services, including family 
planning by 2030 (Way, 2015). 
13.6 Conclusion 
 “Even in states with few maternal deaths, mortality reviews are 
important, because case studies become powerful tools for 
driving change in clinical practice and statewide policy 
decisions.” 
      - D’Alton et al., 2014 
 Despite an international decrease in maternal mortality, it has been on the rise in 
the United States. In 2010, the Joint Commission issued a Sentinel Alert entitled 
“Preventing Maternal Death” (D’Alton et al., 2014). While the United Kingdom’s CEMACH 
is recognised internationally as the gold standard for maternal mortality reviews, the seeds 
of a federal system in the United States to review maternal deaths have been sown in the 
form of the Maternal Mortality Review Information App (MMRIA or “Maria”) led by the CDC. 
MMRIA was used to collect data from 4 states from various time periods: Colorado (2008-
2012), Delaware (2009-2014), Georgia (2012-2013) and Ohio (2008-2012). Each state 
used several forms per maternal death: one death certificate, autopsy report, birth 
certificate (parent section), prenatal care record, social and psychological profile, and 
committee review form. There were also one or more birth certificates (infant or foetal 
death section), emergency room visits and hospitalizations, other medical office visits, and 
informant interviews forms. MMRIA linked death certificates to foetal death and birth 
certificate for the period during which a woman was pregnant to within 365 days of 
delivery. Within each state, a maternal mortality review committee (MMRC) composed of 
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individuals similar to those included in this study, plus forensic pathology, mental, 
behavioural and public health, social work and patient advocates reviewed the cases. 
They were asked to review 6 key questions:  
1. Was the death pregnancy-related?  
2. What was the cause of death?  
3. Was the death preventable?  
4. What were the critical contributing factors to the death?  
5. What are the recommendations and actions that address those contributing 
factors?  
6. What is the anticipated impact of those actions if implemented?  
 Already, with just the 4 trial states, interesting revelations about maternal death in 
the United States have been unearthed. One of them is the important role of mental health 
in maternal mortality, which is expounded on below. In 2016, the CDC approached 30 
states about their maternal mortality review process. As states buy in to this collaborative 
system, they will be able to contribute data to a nationwide review system (Brantley, 2017). 
13.6.1 Maternal mental health  
 A recent study from the University of Colorado Anschutz campus found that self-
harm is the leading cause of maternal mortality in that state, ahead of medical conditions 
and accidental deaths. The study reports an MMR from self-harm of 9.7 per 100,000 live 
births, 90% of which were in the postpartum period (up to 365 days after giving birth). 
During the study period, drug overdose was more common than suicide. Overdose was 
chiefly due to opioid-based pharmaceutical painkillers. Asphyxia by hanging was the main 
method of suicide.  
 A plausible explanation for the increased frequency of mental health disorders 
during and after pregnancy is that many women are advised to discontinue 
antidepressants when they discover they’re pregnant. The risks versus benefits of ceasing 
antidepressants and related classes of medications should be at the front of a physician’s 
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mind when he or she encounters a new diagnosis of pregnancy in a patient on these 
medications (Metz, 2016). 
 Another stressor on new mothers may be the short duration of maternity leave in 
the United States. Currently, the United States has one of the lowest maternity leave 
policies worldwide. The Family and Medical Leave Act (FMLA) of 1993 requires 
companies to provide 12 weeks of unpaid leave to all new mothers (Digital Journal, 2012). 
Along with Papua New Guinea, Swaziland, Liberia and Lesotho, the United States has the 
shortest legal duration of maternity leave. Australia offers up to 12 months of maternity and 
paternity leave, up to 18 weeks of which are paid for each partner (Huffington Post, 2012).  
 In Australia, suicide has long been recognized as the leading cause of maternal 
death. There, the same precautions regarding discontinuation of antidepressants is likely 
applicable, as most obstetrician/gynaecologists follow similar guidelines published by their 
respective regulatory bodies (the American Congress of Obstetricians & Gynecologists 
(ACOG) in the United States and the Royal Australia and New Zealand College of 
Obstetricians and Gynaecologists (RANZCOG) in Australia). In addition, a reduction in 
Australian maternal mortality will likely require earlier access to care for the Aboriginal and 
Torres Strait Islander, newly immigrated, and indigent populations. To the candidate’s 
knowledge, there is no push currently for a nationalized audit of maternal deaths, such as 
the CEMACH and now in the United States, the MMRIA. While Australia has certainly 
made an admirable effort to decrease its MMR and keep it low, there is still room for 
improvement. It has not achieved the rate of Scandinavian countries, which have the 
lowest MMR of any region (WHO, 2015). 
13.6.2 Closing remarks 
 A reduction in MMR in developed countries, much like in developing countries, will 
require a multifaceted approach. The front line in the fight to reduce maternal mortality in 
developed countries is usually the obstetrician, general practitioner or midwife. In the 
developing world, it is often the midwife, doula, elders and community. Behind these 
individuals are scientists and clinicians who try to elucidate why maternal deaths occur and 
provide translational research that can improve maternal outcomes. On an even grander 
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scale, epidemiologists and public health advocates attempt to analyse patterns of maternal 
death within their community or neighbouring communities. And above them are the 
government officials who create CVRS systems, require mandatory reporting of maternal 
death, distribute taxpayer dollars for programs like LaMOMS and hopefully attempt to 
provide the greatest maternity care to the greatest number. The common adage “it takes a 
village to raise a child” could be just as easily made into “it takes a village to birth a child.” 
In this way, while the pregnant or postpartum patient may only interact with a couple of 
individuals, hundreds of forces invisible to her are influencing her maternal outcome. 
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15. APPENDICES  
 
Appendix 1 – Patient Profile  
Demographic Information  
ID#  
Maternal age   
Ethnicity   
Gravidity   
Parity   
Insurance status  
Pregnancy  
Time between conception and 
diagnosis of pregnancy  
 
Number of prenatal appointments  
Medications  
Past medical / surgical history   
Family history   
Foetal presentation  
Multiple births  
Placental location   
Pre-pregnancy weight or first booking 
weight  
 
Height (if recorded) and calculated BMI  
Lifestyle factors   
Birth attendant   
Termination of pregnancy   
Lowest haemoglobin (Hb)  
Glucose screen  
Research studies  
Complications of pregnancy  
Interventions – early pregnancy 
(evacuation, laparotomy, hysterectomy, 
transfusion) 
 
Interventions – antenatal (transfusion, 
external cephalic version) 
 
If death occurred antepartum, 
gestational age at death 
 
Labour / Delivery  
Type of labour (spontaneous, 
augmented, induced, no labour, no 
specified) 
 
Interventions – intrapartum (operative 
delivery, symphysiotomy, Cesarean, 
hysterectomy, transfusion) 
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Complications of delivery  
Method of delivery  
Pain relief during labour  
Live birth / still birth   
Puerperium  
Interventions – postpartum 
(evacuation, laparotomy, hysterectomy, 
transfusion, manual removal, return to 
OR) 
 
Interventions – other (general 
anaesthetic, epidural, spinal 
anaesthetic, local anaesthetic, ICU / 
CCU, ventilation) 
 
Complications of puerperium   
Cause of death  
If death occurred postpartum, number 
of days postpartum at death  
 
Classification of death (ICD-9,10)  
Avoidable factors  
Additional comments  
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Appendix 2 – American case characteristics 
 
 
 
 
 
 
 
 
Lifestyle factor defined as self-reported alcohol, tobacco or drug use during pregnancy  
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Routine prenatal care (PNC) defined as point of entry during the first trimester (0-13+6 weeks 
gestational age) 
Late PNC defined as point of entry after the first trimester  
OB = obstetrician; CNM = certified nurse midwife  
C/S = cesarean section; SVD = spontaneous vaginal delivery; VBAC = vaginal birth after cesarean 
section; D&C = dilation and curettage  
GA = general anaesthesia  
IUFD = intra-uterine fetal demise 
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Appendix 3 – Australian case characteristics  
 
 
 
 
Lifestyle factor defined as self-reported alcohol, tobacco or drug use during pregnancy  
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Routine prenatal care (PNC) defined as point of entry during the first trimester (0-13+6 weeks 
gestational age) 
Late PNC defined as point of entry after the first trimester  
OB = obstetrician; CNM = certified nurse midwife  
C/S = cesarean section; SVD = spontaneous vaginal delivery; VBAC = vaginal birth after cesarean 
section; D&C = dilation and curettage  
GA = general anaesthesia  
IUFD = intra-uterine fetal demise 
 
 68 
Appendix 4 – International Journal of Gynaecology and Obstetrics Article 
 
CLINICAL ARTICLE 
 
A review of the preventability of maternal mortality in one hospital system in 
Louisiana, USA 
 
James J Morong 1,*, Jane K Martin 1,2, Robert S Ware 3,4, Alfred G Robichaux III 1,5 
 
1 The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, 
LA, USA 
2 Department of Obstetrics and Gynecology, Ochsner Clinic Foundation, New Orleans, LA, 
USA 
3 Child Health Research Centre, The University of Queensland School of Medicine, Brisbane, 
QLD, Australia 
4 Menzies Health Institute Queensland, Griffith University, Brisbane, QLD, Australia 
5 Department of Maternal Fetal Medicine, Ochsner Clinic Foundation, New Orleans, LA, USA 
 
 
* Correspondence 
 
James Morong, Department of Maternal Fetal Medicine, 2700 Napoleon Avenue, New 
Orleans, LA 70115, USA. 
Email: james.morong@uq.net.au 
 
 
Keywords: Death; Louisiana; Maternal mortality; Maternal mortality ratio; Preventability; 
USA
 69 
 
Synopsis: The factors most predictive of mortality were late entry to prenatal care, critical 
status requiring transfer from an outside facility, and non-private insurance status. 
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ABSTRACT 
 
Objective: To determine preventability of in-hospital maternal mortality in the Ochsner 
Health System (OHS) in the USA. 
Methods: A retrospective study was undertaken of all known cases of in-hospital maternal 
death (during pregnancy or within 42 days of termination) that occurred within OHS 
facilities in 1995–2013. Associations between characteristics and mortality and 
preventability were investigated. Incidence rate ratios (IRRs) were calculated in view of 
varying reference values. 
Results: Among 16 eligible deaths, 12 (75%) were deemed potentially preventable. The 
incidences of overall and preventable maternal death were higher if the patient had late 
entry to prenatal care (IRR 6.3 [P=0.004] and 8.8 [P=0.004], respectively). Maternal 
mortality was increased if the patient had required transfer to the OHS (IRR 15.8 [P<0.001] 
for overall and, 15.8 [P=0.002] preventable mortality). Deaths of patients with private 
insurance were more likely to be not preventable than were those of patients without such 
insurance (P=0.003). Uninsured patients had the highest MMR, with an IRR of 13.8 
(P=0.014) when compared with Medicaid patients. 
Conclusion: The factors most predictive of mortality were late entry to prenatal care, 
critical status requiring transfer from an outside facility, and non-private insurance status. 
 71 
1 INTRODUCTION 
 
United Nations Millennium Development Goal 5 sought to achieve a 75% reduction in the 
maternal mortality ratio (MMR) between 1990 and 2015.1 Every 3–5 years, an interagency 
group led by WHO publishes estimates of MMR—i.e. the number of maternal deaths per 
100 000 live births, with maternal death defined as “the death of a woman while pregnant or 
within 42 days of termination of pregnancy, irrespective of the duration or site of the 
pregnancy, from any cause related to or aggravated by the pregnancy or its management 
but not from accidental causes”2—for nearly every country worldwide. 
 
 
The USA is one of the few countries worldwide with a rising MMR: the Maternal Mortality 
Estimation Inter-Agency Group has shown that maternal mortality has been increasing over 
the last two decades, with the most recent estimate of 14 maternal deaths per 100 000 live 
births in 2015.3 A possible confounding factor is the inclusion of a separate pregnancy 
question on the US Standard Certificate of Death, which could account for some of the 
increase in MMR in the USA during its implementation in 2002– 2003; however, it does not 
explain the overall trend.4,5 
 
Trends in maternal mortality on a national or statewide level in the USA are well studied, but 
there is a paucity of literature analyzing maternal mortality within one hospital system.3,6 
Case studies within a hospital or hospital system could help to change clinical practice and 
inform statewide policy.7 The aim of the present study was to review cases of in-hospital 
maternal mortality in Ochsner Health System (OHS) from 1995 to 2013 to 
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assess potential preventability and elucidate possible explanations for the trend toward 
increasing maternal deaths. Preventability was classified using the most widely accepted 
method developed by epidemiologist Dr. Stacie Geller, which applies ten systems- and 
provider-based failures of care and two patient-based failures of care to cases of maternal 
death.8,9 
 
2 MATERIALS AND METHODS 
 
A retrospective study was undertaken of in-hospital maternal deaths within the OHS from 
January 1, 1995, to December 31, 2013. OHS is a large, multi-hospital system serving 
pregnant women in southeast Louisiana and the Gulf Coast, providing a high level of acute 
care for high-risk and complicated pregnancies. All OHS facilities were included in data 
collection. Once OHS institutional review board approval was gained, charts were assessed 
for eligibility. A case of maternal death was included if it met the WHO criteria for maternal 
death, occurred in a hospital within the OHS, and occurred in the study period. These 
inclusion criteria are narrower than the WHO criteria for maternal death because they 
exclude violent deaths, accidental deaths, or any death outside the hospital setting. Although 
other metrics for assessing maternal mortality exist—e.g. the pregnancy-related mortality 
ratio published by the Centers for Disease Control and Prevention, which includes deaths 
within 365 days of pregnancy—the WHO definition of MMR was used in the present study to 
allow comparison of maternal mortality in the USA with that in other countries in future 
research. The OHS institutional review boards, acting as a privacy board, issued a Health 
Insurance Portability and Accountability Act of 1996 waiver for the study, allowing data 
access without informed
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consent. 
 
Initially, 104 charts were identified by linking codes from the International Classification of 
Diseases (9th edition) and Current Procedural Terminology specific to pregnancy with a 
discharge code of deceased in the period of interest. Patients were identified using multiple 
medical records systems, including Epic electronic medical records and paper documents. 
Other facilities and practitioners were contacted when appropriate. This initial survey 
identified deaths beyond the 42 days specified by the WHO criteria; therefore, it was 
necessary to select only charts meeting the WHO criteria of maternal death (17 total). One of 
the 17 charts was eliminated because the patient received obstetric care in the OHS but died 
outside a hospital setting. 
 
A patient profile (Box S1) was generated for each case through detailed chart review. The 
profile sought to create a chronological account of a woman’s pregnancy and the events 
leading up to her death, including demographic information, past medical and surgical 
history, and complications of pregnancy, delivery, and/or the puerperium. Once profiles 
were collected, a multidisciplinary team composed of two maternal–fetal medicine 
specialists, four obstetrician/gynecologists, one certified nurse-midwife, one labor and 
delivery charge nurse, and two obstetrics anesthesiologists was assembled at a round table 
conference. Dr. Geller was consulted on implementation of the multidisciplinary team 
review on the basis of her previous work.10 The multidisciplinary team received a tutorial on 
the study and method of classifying deaths, then reviewed each case and assigned 
preventability classifications. 
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Members of the multidisciplinary team were instructed to envision maternal mortality on a 
continuum from healthy pregnancy to minor morbidity to major morbidity to death. 
 
 
Women can enter the continuum at any point but, for the purposes of the present study, they 
were united by the common endpoint of death. Dr. Geller has defined an event as 
preventable “if it could have been avoided by any action or inaction on the part of the health 
care provider, the system, or the patient that may have caused or contributed to progression 
to more severe morbidity or death.”9 With this definition, team members 
were instructed to complete three tasks. First, they were asked to reach a consensus 
opinion about whether the death was preventable, potentially preventable with a definite 
improvement in care necessary, or not preventable. Second, if the death was preventable 
or potentially preventable, they were asked to reach a majority opinion about whether there 
was a degree of provider failure, systems failure, patient failure, or any combination of 
these. Third, they were asked to reach a majority opinion about whether the woman entered 
her pregnancy in a healthy state, with minor morbidity, or with major morbidity.8,10 A healthy 
state was defined as no medical conditions on entering pregnancy. Minor morbidity was 
defined as potentially life-limiting conditions (e.g. hypertension, diabetes, or obesity) that 
required observation and management during pregnancy. Major morbidity included life-
limiting or life-threatening conditions such as malignancy or cardiomyopathy. 
 
All study data were presented as frequency (percentage). Demographic characteristics 
were correlated with maternal death and preventability. Population-level data from the
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Louisiana Office of Public Health specific to the OHS were provided for the same 
demographic characteristics to calculate specific MMRs: the total number of live births 
within the study period in the group with a specific characteristic was used as the 
denominator, and the number of cases of maternal deaths in that group was used as the 
numerator. Incidence rate ratios (IRRs) were computed by comparing the incidence rate of 
death (per 100 000 live births) between two populations. Poisson regression models were 
used to calculate MMRs and IRRs with 95% Wald-based confidence intervals. 
 
 
The association between patient characteristics and preventability status is reported as a 
relative risk (RR). RR was determined by comparing the percentage of potentially 
preventable deaths with a certain characteristic with that of deaths that were not preventable 
but had the same characteristic. Significance was calculated using the Fisher exact test. 
P<0.05 was considered statistically significant. Statistical analysis was undertaken using 
Stata statistical v13.1 (StataCorp, College Station, TX, USA). 
 
 
3 RESULTS 
 
A total of 16 charts were deemed eligible for inclusion in the present study. Almost two- 
thirds of the patients entered pregnancy with major morbidity (Table 1). 
 
Because of the rarity of maternal mortality and the consequent small number of cases, 
deaths classified as preventable or potentially preventable were analyzed together 
(henceforth referred to as “potentially preventable”) and compared with deaths that were 
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not preventable. Four (25%) deaths were deemed not preventable and 12 (75%) were 
deemed potentially preventable. Of the 12 potentially preventable deaths, 9 (75%) were 
linked with provider-based failures, 9 (75%) with systems-based failures, and 6 (50%) with 
patient-based failures. The most commonly encountered provider-based failures were 
delays in assessment/evaluation of a patient (approximately 3 cases), delay or failure in 
diagnosis/recognition of high-risk status (approximately 6 cases), and delay in referral to an 
expert (approximately 5 cases). The most commonly encountered systems-based failures 
were communication issues of all types (between providers, departments, hospitals, and 
patients; approximately 9 cases). The most common patient-based failures included failure 
to seek care or inadequate prenatal care (approximately 3 cases), and belief systems such 
as refusal of antibiotics, blood products, or procedures (approximately 2 cases). 
 
 
Late entry into prenatal care—defined as first prenatal visit during or after 14 weeks of 
pregnancy—was associated with an increased risk of maternal mortality in terms of both 
overall maternal deaths (Table 2) and potentially preventable deaths (Table 3) (P=0.004 for 
both). 
 
 
With regard to insurance accommodation, 5 (31%) patients in the present study had 
private insurance, 9 (56%) had Medicaid, and 2 (13%) were uninsured. All the 
unpreventable deaths occurred in the population with private insurance. All deaths in the 
Medicaid and uninsured populations, and one in the population with private insurance 
were considered potentially preventable. Mandatory reported of insurance 
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data on the birth certificate at the state level began in December 2010; therefore, 
analyses included only the eight maternal deaths (6 Medicaid and 2 uninsured) that 
occurred from this point onwards.The fact that eight of the 16 cases were from the last 3 
years of the 18- year study period indicates that the national trend of increasing maternal 
deaths is reflected in the study population. 
 
 
The calculated MMR for Medicaid patients was 58.3 in the overall and potentially 
preventable categories (Tables 2 and 3). The uninsured population yielded the most 
significant MMR (Tables 2 and 3). A significant association was found for the IRR of 
maternal death in an uninsured patient when compared with a Medicaid patient (P=0.014) 
(Tables 2 and 3). A significant association between preventability and specific demographic 
characteristics was found only for private insurance accommodation (P=0.003) (Table 4). 
 
 
Almost half the included patients had been transferred within or to the OHS at some 
stage of their care because of a requirement for a higher level of care (Figure 1). 
Patients who transferred to OHS had an MMR of 426.9 and 320.2 in the overall and 
potentially preventable maternal death categories, respectively (Tables 2 and 3). The IRR 
of maternal death in a patient transferred was 15.8 overall and in the potentially 
preventable category (Tables 2 and 3). Three-quarters of the potentially preventable 
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deaths after transfer were linked with provider- and systems-based failures before their 
transfer (Figure 1). 
 
 
4 DISCUSSION 
 
In the present study, Medicaid insurance, late entry into prenatal care, and transfer from an 
outside facility were shown to be associated with maternal mortality within the OHS. These 
associations were also present when only potentially preventable deaths were considered. 
The only factor found to be specifically associated with preventability was private insurance. 
Provider- and systems-based failures were common among potentially preventable deaths 
that occurred after transfer to the OHS. 
 
 
The vast majority of maternal deaths—especially those that were potentially preventable—
occurred among patients with Medicaid and without any insurance. Private insurance was 
inversely correlated with risk of preventable death, and maternal mortality rates increased 
substantially from private insurance to Medicaid to uninsured status. The two patients who 
had no insurance entered pregnancy in a state of major morbidity, and both deaths were 
considered potentially preventable, with adverse events occurring at the time of delivery. 
Neither patient had a documented visit with a high-risk specialist, despite their documented 
comorbidities. Insurance accommodation is linked with a woman’s ability to seek prenatal 
care. Closer monitoring of a high-risk pregnancy might have been achieved had these 
uninsured patients acquired Medicaid during their pregnancy. 
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The present study also stresses the importance of having a low threshold to transfer 
critically ill patients to a tertiary care center early in the course of their illness. All the 
patients whose deaths after transfer to the OHS were classified as potentially preventable 
(n=3) were transferred with either anoxic brain injury in a comatose state or with multi-
organ failure. Patients who are deemed “sick enough” for transfer are probably already 
critically or lethally ill by the time they begin undergoing care at a higher level care center. It 
is paramount to have a low threshold to transfer high-risk obstetric patients to tertiary 
centers, where specialized consultant care and state-of-the- art technology can improve a 
patient’s course and outcome. 
 
 
The major limitation of the present study was the sample size. Because of the statistical 
rarity of maternal mortality in high-income countries, it is difficult to establish any specific 
causality, despite the trend toward increasing MMR in the USA. Additionally, the results 
would have been greatly affected if even one eligible chart had been missed. Once a 
patient had a pregnancy-related diagnosis, it would have been retained in her electronic 
medical record and would have been identified by coders in the study if she was also 
designated as deceased; however, a patient early in her pregnancy without any pregnancy-
related codes, a miscoded patient, or a patient not designated as deceased could have 
been missed. 
 
 
To our knowledge, the present study is the first to extrapolate maternal mortality data for an 
individual hospital system and for various demographic characteristics. A prior study 
conducted by Geller et al.11 used the same definition of preventability to look at 610
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maternal deaths within the US state of Illinois in 2002–2012. This study had some parallels 
with the present one. First, Medicaid was cited as the source of insurance for most patients 
who died. Second, similar preventable factors were identified, such as failure to identify the 
patient as high risk (provider-based) and non-compliance with treatment (patient-based).11 
According to Callahan,12 the prevention of maternal deaths will probably require provider 
adherence to best practice measures and systems-based 
improvements in defining maternal early warning criteria and conducting preventability 
reviews when an adverse event occurs. 
 
 
Although the small sample size of the present study certainly brings its own challenges 
when drawing conclusions, the findings should encourage hospital systems to critically 
analyze current practices to predict and prevent poor maternal outcomes. Within the OHS, 
the preventability form used in the present study is now being used in real time, rather than 
retrospectively, to analyze adverse maternal outcomes and near-miss events. Hopefully, the 
present investigation will create a foundation for other hospital systems to use when 
creating their own maternal mortality review process. 
 
 
Author contributions 
 
JJM designed the project, with supervision from AGR. JJM, JKM, and AGR planned the 
project, reviewed charts, and wrote the paper. RSW analyzed data and contributed to the 
writing of the relevant sections of the paper. 
 
 
Conflict of interest
 81 
The authors have no conflicts of interest. 
 82 
REFERENCES 
 
1 World Health Organization. “Goal 5: Improve Maternal Health” 
http://www.un.org/millenniumgoals/maternal.shtml. Accessed May 15, 2016. 
2 World Health Organization. “Maternal mortality ratio (per 100,000 live births). 
http://www.who.int/healthinfo/statistics/indmaternalmortality/en. Accessed June 6, 2016. 
3 Trends in maternal mortality: 1990 to 2015: estimates by WHO, UNICEF, UNFPA, 
World Bank Group and the United Nations Population Division. Geneva: World Health 
Organization; 2015. 
4 Hogan, Margaret C, Foreman, Kyle J, Naghavi, Mohsen, Ahn, Stephanie Y, Wang, 
Mengru, Makela, Susanna M. et al. “Maternal mortality for 181 countries, 1980– 2008: a 
systematic analysis of progress towards Millennium Development Goal 5” Lancet 2010; 
375: 1609–23 
5 Hoyert DL. Maternal mortality and related concepts. National Center for Health 
Statistics. Vital Health Stat 3(33). 2007. 
6 National Women’s Law Center. Louisiana: Health Care Report Card. 
http://hrc.nwlc.org/states/louisiana. Accessed June 6, 2016. 
7 D’Alton, Mary E, Main, Elliott K, Menard, M. Kathryn, Levy, Barbara S. The 
National Partnership for Maternal Safety. Am J Obstet Gynecol 2014;0:1-5. 
8 Cox SM, Kilpatrick SJ, Geller SE. “A descriptive model of preventability in 
maternal morbidity and mortality” J Perinatol (2006) 26, 79–84 
9 Geller, Stacie E, Rosenberg, Deborah, Cox, Suzanne M, Brown, Monique L, 
Simonson, Louise, Driscoll, Catherine A et al. “The continuum of maternal morbidity and 
mortality: factors associated with severity” Am J Obstet Gynecol 2004 191, 939-44. 
 83 
10 Lawton Beverly, MacDonald Evelyn J, Brown Selina A, Wilson, Leona, Stanley, 
James, Tait, John D et al. “Preventability of severe acute maternal morbidity” Am J Obstet 
Gynecol 2014;210:x.ex-x.ex 
11 Geller, SE, Koch, AR; Martin, NJ, Rosenberg, D, Bigger, HR. “Assessing 
preventability of maternal mortality in Illinois: 2002-2012” Am J Obstet Gynecol 
2014;211:698.e1-11. 
12 Callahan, WM. State-based maternal death reviews: assessing opportunities to alter 
outcomes. Am J Obstet Gynecol 2014 
 84 
Figure legend 
 
Figure 1 Transfers to the Ochsner Health System. a One transferred within the Ochsner 
Health System. 
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Supporting information legends 
 
Box 1 Patient profile, used to extract information from each patient chart pertaining to 
pregnancy, delivery, puerperium, and death. 
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Table 1 Demographic characteristics (n=16). 
Characteristic Value a 
Age, y 28.8 (19–37) 
White ethnic origin 9 (56) 
Body mass index at death b 30.6 (16.1–54.9) 
Medications taken daily c 2 (0–12) 
Prenatal  appointments d 9.3 (0–29) 
Lifestyle factors complicating pregnancy e 6 (43) 
Entered pregnancy in a healthy state 2 (13) 
Entered pregnancy with minor morbidity 4 (25) 
Entered pregnancy with major morbidity 10 (63) 
Primigravid 3 (19) 
Private insurance 5 (31) 
Receiving general anesthesia 5 (31) 
Transferred at some point in care f 5 (31) 
a Values are given as mean (range) or number (percentage). 
b Calculated as weight in kilograms divided by the square of height in meters. Unknown for two cases. c 
All medications taken during pregnancy excluding prenatal vitamins, folate, and iron. Unknown for 1 
case. 
d When a range was given (5–7 for 2 cases), the average was used. Unknown for 4 cases. 
e Any alcohol, tobacco, or illicit drug consumption during pregnancy; does not include previous use. 
Unknown for 2 cases. 
f Does not include admission to the intensive care unit. 
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Table 2 Associations between characteristics and maternal mortality (n=16). 
Characteristic Cases Total 
live 
births 
Deaths per 100 000 
live births (maternal 
mortality ratio) 
Incidence rate ratio 
(95% confidence 
interval) 
P  value a 
Ethnic  origin b      
White 9 21 575 41.7 1.0 – 
Black 6 19 218 31.2 0.8 (0.3–2.1) 0.616 
Transfer from 
outside facility 
     
No 12 44 599 26.9 1.0 – 
Yes 4 937 426.9 15.8 (5.1–48.9) <0.001 
Insurance c      
Private 0 5208 0.0 – – 
Medicaid 6 10 295 58.3 1.0 – 
Uninsured 2 249 803.2 13.8 (2.8–67.9) 0.014 
Age, y 
≤24 4 15 772 25.4 0.6 (0.2–1.9) 0.430 
25–34 10 23 774 42.1 1.0 – 
≥35 2 6044 33.1 0.8 (0.2–3.6) >0.99 
Entry into prenatal 
care d 
1st trimester 
(routine) 
5 37 560 13.3 1.0 – 
Late or none 6 7147 84.0 6.3 (1.9–20.6) 0.004 
Parity      
Nulliparous 3 19 018 15.8 1.0 – 
Multiparous 13 29 627 43.9 2.8 (0.8–9.8) 0.125 
a Refers to incidence rate ratio. 
b Unknown for 1 case 
c Insurance data available from December 6, 2010, onwards. 
d Data not available for 5 cases. 
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Table 3 Associations between characteristics and potentially preventable maternal mortality (n=12). 
Characteristic Cases Total 
live 
births 
Deaths per 100 000 
live births (maternal 
mortality ratio) 
Incidence rate ratio 
(95% confidence 
interval) 
P  value a 
Ethnic origin      
White 6 21 575 27.8 1.0 – 
Black 6 19 218 31.2 1.1 (0.4–3.5) >0.99 
Transfer from 
outside facility 
     
No 9 44 599 20.2 1.0 – 
Yes 3 937 320.2 15.8 (4.2–58.3) 0.002 
Insurance b      
Private 0 5208 0.0 – – 
Medicaid 6 10 295 58.3 1.0 – 
Uninsured 2 249 803.2 13.9 (2.8–67.9) 0.014 
Age, y 
≤24 3 15 772 19.0 0.6 (0.2–2.5) 0.749 
25–34 7 23 774 29.4 1.0 – 
≥35 2 6044 33.1 1.1 (0.2–5.4) >0.99 
Entry into prenatal 
care c 
1st trimester 
(routine) 
3 37560 8.0 1.0 – 
Late or none 5 7147 70.0 8.8 (2.1–36.6) 0.004 
Parity      
Nulliparous 2 19 018 10.5 1.0 – 
Multiparous 10 29 627 33.8 3.2 (0.7–14.6) 0.144 
a Refers to incidence rate ratio. 
b Insurance data available from December 6, 2010, onwards; incidence rate ratios not calculated.  
c Data not available for 4 cases. 
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Table 4 Association between factors affecting maternal mortality and preventability.a 
Factor Not preventable 
(n=4) 
Potentially 
preventable (n=12) 
Relative risk (95% 
confidence interval) 
P value 
Major morbidity 3 (75) 7 (58) 0.8 (0.4–1.6) >0.99 
Black ethnic origin b 0 6 (50) – 0.229 
Private insurance 4 (100) 1 (8) 0.1 (0.0–0.5) 0.003 
Obstetrician attending 
birth 
2 (50) 3 (25) 0.5 (0.1–2.0) 0.547 
Transferred from 
outside facility 
1 (25) 3 (25) 1.0 (0.1–7.1) >0.99 
Transferred to higher 
level of care 
0 2 (17) – >0.99 
Delivery within 
Ochsner Health 
System 
3 (75) 7 (58) 0.8 (0.4–1.6) >0.99 
Late or no prenatal 
care c 
1 (33) 5 (63) 1.9 (0.4, 10.1) 0.545 
Multiparous 3 (75) 10 (83) 1.1 (0.6, 2.1) >0.99 
a Values are given as number (percentage) unless indicated otherwise. 
b Unknown for 1 unpreventable case. 
c Entry into prenatal care unknown for 1 not preventable case and 4 potentially preventable cases. 
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Background: It is well documented that the American maternal mortality ratio has increased 
over the years 2000 - 2015. The Australian maternal mortality ratio, in contrast, has 
decreased over the same time period, a trend common among most Western countries.  
Methods: This study was a retrospective cohort study of cases of in-hospital maternal deaths 
within the Ochsner Health System (Louisiana, USA) and Queensland Health System 
(Australia) from 1995 to 2013. The aim was to determine if American and Australian women 
have a similar rate of preventable maternal death and if the deaths were attributable to the 
same factors. Charts were assessed for preventability by a multidisciplinary team. 
Results: There were 16 eligible charts identified within the Ochsner Health System and 15 
within the Queensland Health System. In the American cohort, deaths in the private insurance 
group (n=5) were least likely to be preventable (p=0.003). Australian maternal deaths were 
less likely to occur among women with late or no pre-natal care than in American women, risk 
difference = 44.5% overall (95%CI=9.7%, 79.4%; p=0.03) and 50.0% for potentially 
preventable deaths (95%CI=9.3%, 90.6%; p = 0.04).   
Conclusions: Women from Louisiana, USA, and Queensland, Australia, have similar rates of 
preventable maternal death There were no statistically significant factors to explain trends in 
Australian maternal death; American maternal mortality was significantly associated with point 
of entry into prenatal care, likely influenced by insurance status. Furthermore, the majority of 
deaths in this group were complicated by hospital systems-based factors.  
 
Introduction  
 
In 2000, when United Nations Millennial Development Goal 5 was identified as demonstrating 
the slowest worldwide progress, a global commitment was made to achieve its two parts: a 
75% reduction in maternal mortality ratio (MMR) from 1990 – 2015 and provision of universal 
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access to reproductive health. MMR is defined as maternal deaths per 100,000 live births, 
where maternal death is defined in the International Classification of Diseases, 10th Edition 
(ICD-10) as “the death of a woman while pregnant or within 42 days of termination of 
pregnancy, irrespective of the duration or site of the pregnancy, from any cause related to or 
aggravated by the pregnancy or its management but not from accidental causes.”1 The United 
States is the only developed country to show an increase in MMR between 1990 and 2015, 
rising from 12 to 14, a 16.7% increase. i 
The authors Morong et al. previously conducted a multi-center study of the preventability of 
maternal mortality in Louisiana within the Ochsner Health System (OHS).ii OHS is a multi-
hospital tertiary care center and referral center serving pregnant women in southeast 
Louisiana and the Gulf Coast and is one of the three major birthing centers in Orleans parish, 
which held the majority of cases in this study. Louisiana has the 6th highest MMR in the USA 
with a rate of 17.9 in 2010.iii Morong et al. reported a statistically significant association 
between preventable maternal death and Medicaid or self-pay insurance accommodation, late 
entry into prenatal care, and patient status requiring transfer to OHS. These findings were the 
motivation to conduct a comparative study to determine if the same factors contribute to 
maternal death in a Western country with low MMR.  
Australia proved to be the ideal country for comparison: it has low maternal mortality that has 
been decreasing over the same period that the United States’ MMR has been increasing. In 
Australia, MMR fell by 25% from 1990 to 2015.1 Australia and the United States have similar 
levels of wealth, as measured by Gross Domestic Product (GDP) per capita on Purchasing 
Power Parity (PPP).iv They also have similar rates of medical comorbidities known to affect 
pregnancy, such as hypertension, diabetes and obesity. v,vi Furthermore, all Australian citizens 
and permanent residents are eligible for public health insurance under a socialized system, 
providing an interesting point of comparison to the United States’ health system during the 
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study period. Consequently, the aim of this study is to determine whether Americans and 
Australians have a similar rate of preventable maternal death and if the deaths were 
attributable to the same factors. 
 
Methods  
 
A retrospective cohort study of all known cases of in-hospital maternal deaths within the OHS 
and Queensland Health system (QHS) was conducted. (Fig. 1) The QHS encompasses all 
public hospitals within the state of Queensland, an Australian state with a population of 
approximately 4.7 million residents. There are 16 Health and Hospital Services (HHS) 
spanning the state, each of which is a statutory body governing many hospitals and clinics.  
Three HHS were approached for a total of 7 hospitals included; one, the Mater Mothers’ 
hospital, is not part of the QHS. It is worth noting that not all hospitals within the QHS are 
maternity hospitals. Initial IRB approval was granted by the Royal Brisbane and Women’s 
Hospital IRB and this was expanded to include all Queensland hospitals with a Queensland 
Health Statistics Branch (HSB) IRB approval. Approval through the OHS was based on Royal 
Brisbane and Women’s Hospital IRB approval, the first time this IRB has approved a project 
based on a foreign permission. A waiver of consent was issued for all hospital sites through a 
Public Health Act application. Individual hospitals’ Site Specific Applications were completed 
when requested.   
Charts were identified within the OHS by obstetric diagnosis related group and discharge 
code of deceased within the period January 1, 1995 – December 31, 2013. There are eleven 
hospitals within the OHS, all of whom were examined for inclusion. As with the QHS, not all 
Ochsner hospitals offer maternity services. Of the 104 charts identified and reviewed, 16 fit 
the inclusion criteria of (a) meeting the WHO definition of maternal mortality and (b) death 
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within a hospital. In the QHS, the HSB provided linkage data between the Queensland 
Perinatal Data Collection (PDC) and Death records and the Queensland Hospital Admitted 
Patient Data Collection (QHAPDC) and Death records. vii,viii The PDC and QHAPDC are 
government maintained electronic records of all births and all admitted hospital patients in 
Queensland, respectively. Initial identification was based on ICD-9 and ICD-10 codes as well 
as text search for the words “maternal,” “obstetric,” “pregnant,” “labor,” “puerperium,” and/or 
“placenta” in the cause of death field. 
The Queensland HSB was responsible for extracting patient charts that fit the inclusion 
criteria and ensuring patients weren’t counted twice. (Fig. 2) A total of 75 charts were initially 
identified by the HSB for inclusion. Charts were accessed at all facilities where ethical 
approval was granted during the years that the study was ongoing and where a research 
investigator was present. This limited the geographic scope of the study to south-eastern 
Queensland. The investigators reviewed 18 charts and 15 were ultimately included. Three 
were excluded because cause of death was missing. In all three cases, a paucity of data 
prevented evaluation by the multidisciplinary team (MDT) described below.  
A multidisciplinary team (MDT) of 10 obstetrician / gynecologists, maternal-fetal medicine 
specialists, anesthesiologists and nurses convened on two separate occasions to review the 
31 cases. These 31 cases represented all cases identified within the OHS and all cases 
where an investigator was present within the QHS. The team was asked to reach a 
consensus decision if the deaths were preventable, potentially preventable or not preventable 
based on a literature search that yielded unanimous support of the preventability 
classifications put forth by Geller et al. at the University of Illinois, Chicago. This methodology 
required members of the MDT to classify preventable deaths as those that could have been 
avoided by any “action or inaction on the part of the health care provider, the system, or the 
patient that may have caused or contributed to progression to more severe morbidity or 
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death.” ix This method has high inter-rater reliability (overall agreement 77%, Cohen’s kappa 
0.49). x Due to the rarity of maternal mortality and the consequent small number of identified 
cases, deaths classified as preventable or potentially preventable were analyzed together 
(henceforth referred to as “potentially preventable”) and contrasted with not preventable 
deaths.  
The MDT was further asked to reach a majority decision if preventable and potentially 
preventable deaths were also complicated by provider-, systems- or patient-based failures of 
care, or some combination thereof. A full list of the failures identified by the MDT is available 
as supplemental information to the article Establishment of a national severe maternal 
morbidity preventability review in New Zealand by MacDonald et al.11 The same definitions 
were used in the American and Australian cohorts. Finally, the MDT was asked to reach a 
majority decision if the patient entered her pregnancy in a healthy state or with minor or major 
morbidity.  
Summary statistics are presented as frequency (percentage) for categorical outcomes and 
mean (range) for continuous outcomes. The association between patient characteristics and 
cohort (Louisiana/Queensland) and type of death (potentially preventable/not preventable) is 
examined using Fisher’s Exact Test for categorical outcomes and the Mann-Whitney U test 
for continuous outcomes. The association between clinical characteristics and cohort is 
reported using risk difference (RD) and 95% confidence intervals. RD was calculated by 
subtracting the Australian risk from the American risk; a positive RD favors the Australian 
cohort, a negative one favors the American. All available data points were analysed for each 
outcome, with missing data excluded on an item-by-item basis,  A p-value less than 0.05 was 
considered statistically significant. Statistical analysis was undertaken using Stata statistical 
software v13.1 (StataCorp, College Station, TX, USA). 
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Results  
 
Demographic, social and clinical characteristics are displayed in Table 1. There were no 
statistically significant differences in characteristics between the cohorts, though there was a 
trend for Australian women to be older (mean = 32.5 years v. 28.8 years, p=0.14) and less 
likely to have private insurance (6.7% v. 31.3%, p=0.17).  
75.0% of American deaths (n=12) and 73.3% of Australian deaths (n=11) were deemed 
potentially preventable. Of the American deaths, 3 (75.0%) of the not preventable deaths and 
7 (58.3%) of the potentially preventable deaths entered their pregnancy with major morbidity 
(RD=16.7%, 95%CI=-34.1%, 67.4%; p=1.00). Of the Australian deaths, 2 (66.7%) of the not 
preventable deaths and 5(45.5%) of potentially preventable deaths entered with major 
morbidity (RD=21.2%, 95%CI=-39.7%, 82.1%; p=0.71). There was no statistically significant 
risk difference for preventable death between Australian or American woman entering their 
pregnancy with major morbidity (RD =12.9%, 95%CI=-27.7%, 53.4%; p=0.54). 
The MDT classified potentially preventable deaths as provider-based, systems-based, and/or 
patient-based failures. 9 (75.0%) of the potentially preventable American deaths were thought 
to be complicated by provider-based failures of care, 9 (75.0%) by systems-based failures 
and 6 (50.0%) by patient-based failures. Of the potentially preventable Australian deaths, 
8(72.7%) were thought to be complicated by provider-based failures of care), 6 (54.5%) by 
systems-based failures and 7 (63.6%) by patient-based failures.  
Looking at the two cohorts separately, preventability of Australian maternal mortality could not 
be significantly linked to any demographic qualifier. (Table 2) In the American cohort, 
however, private insurance accommodation is less correlated with preventable maternal 
mortality (p=0.003) (Table 3).   
 98 
Comparing the two cohorts, late point of entry into prenatal care – defined as after 14 weeks 
gestational age – or no prenatal care, was correlated with a higher risk of overall death (RD = 
44.5%, 95%CI=9.7%, 79.4%; p=0.03) and potentially preventable death (RD =50.0%, 
95%CI=9.3%, 90.6%; p = 0.04) in the American cohort compared to the Australian (Tables 4 
and 5). No other factors reached statistical significance.  
 
Discussion 
 
Due to the large catchment area of each hospital system, it is our impression that the cohorts 
in this study reflect larger trends in national maternal mortality. The American data in this 
study mirrors national mortality trends, with a majority of cases clustered in the later years of 
the study period. The Australian data reaches peak incidence in 2004 and then tapers off, 
whereas Australian national data shows a peak in 2000 and then a downward trend. 1 The 
relatively small sample size may have meant some analyses were underpowered, particularly 
where there was item-missingness from some demographic and clinical factors – the 
foremost of which was the “late / no entry into prenatal care” category, which was missing 5 
data points from both the American and Australian arms of the study. (Table 2, Table 3, Table 
4) The strengths of this study, however, are the rigorous method of case identification used in 
each country and the thorough account of a woman’s path that was presented to a highly 
trained MDT.  
 
A statistically significant number of American deaths, both preventable and overall, were 
linked to a late point of entry into prenatal care. Numerous factors affect a woman’s decision 
to seek prenatal care including insurance status, patient education, socioeconomic status and 
time when the pregnancy is first confirmed. Our study found that among the American cohort, 
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deaths in the group with private insurance were likely to be not preventable. In fact, 100% of 
the not preventable American deaths were in the private insurance category and only one of 
the 12 potentially preventable deaths had private insurance. Conversely, all deaths in the 
Medicaid and uninsured categories were considered potentially preventable. As a point of 
reference, from 2010 – when insurance data become available at a state-wide level – to 2013 
– when this study was commenced – 33.0% of maternity patients in the OHS had private 
insurance, 65.4% had Medicaid and 1.6% had no insurance according to data made available 
to us by the State of Louisiana Office of Public Health. 
 
The same trends did not hold true in the Australian cohort. Australian maternal mortality could 
not be appreciably linked to any of the demographic factors assessed, indicating deaths there 
are more likely to be random occurrences in this cohort. The authors arrived at the conclusion 
that although they face similar comorbidities in their home countries, pregnant women and 
new mothers in Australia and America encounter different barriers in access to health care. 
Anecdotal evidence would suggest that Australian hospitals serve a more remote population. 
However, with respect to population to hospital ratio (measured as hospital beds per 1,000 
persons) Australia leads the USA at 3.912 to 2.9.13 Interestingly, the American cohort was 
40% African-American (6 of 15, with one case of unrecorded ethnicity) and 60% Caucasian (9 
of 15), whereas the Australian cohort was 46.7% Caucasian (7 of 15, with one case of 
unrecorded ethnicity) and the other 53.3% was a mix of Middle-Eastern, Aboriginal Australian, 
Asian and African. 
 
Finally, Australian Medicare is a publicly funded universal health care system. It allows the 
holder – an Australian citizen or permanent resident – a subsidized rate from practitioners 
who hold a provider number and free care in public hospitals. Private insurance also exists 
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and allows the holder access to a wider range of services or care. Of the Australian hospitals 
surveyed, public insurance accommodation was vastly more common amongst maternity 
patients; the majority of hospitals had 5% or less of patients with private insurance over the 
study period.14 The American healthcare system during the years of our study (i.e. before the 
implementation of the Affordable Care Act) did not require Americans to hold an employer-
sponsored health plan, Medicaid, Medicare or other public insurance program. The Affordable 
Care Act mandated this otherwise the uninsured person risked a penalty.15 
 
Rates of access to prenatal care, in both the not preventable and potentially preventable 
categories, were much lower in the American cohort than the Australian. The authors believe 
difficulties in access to prenatal care may represent financial barriers to care existing in the 
American system that are not inherent in the Australian system. None of the crucial factors 
identified in the first study – point of entry into prenatal care, insurance accommodation or 
transfer to higher level of care – were statistically significant in the Australian arm of the data. 
Australian maternal mortality is and has been much lower than the USA’s since the earliest 
documented WHO data in 1990. We can also conclude that this lower MMR is more likely due 
to chance than the demographic factors we surveyed.  
 
Conclusion 
 
The events leading to a maternal death can be conceptualized as predisposing and 
precipitating factors. Predisposing factors are those that place a woman at a more high-risk 
point on the maternal mortality continuum while precipitating factors are those that accelerate 
her trajectory to ultimate mortality. The largest disparity between the USA and Australia with 
regards to maternal health seems to be in predisposing factors; those, like insurance 
 101 
accommodation and access to prenatal care, that affect the course of her pregnancy before 
delivery. Census data indicates that the USA is still failing to achieve United Nations Millennial 
Development Goal 5A – a 75% reduction in its MMR. But, equally importantly, this study 
suggests the USA is not meeting goal 5B – universal access to reproductive healthcare – 
either.  
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Table 1: Baseline characteristics. Continuous characteristics presented as mean (standard deviation) 
and categorical characteristics presented as frequency (percentage)  
 
 American cohort 
(N=16) 
Australian Cohort 
(N=15) 
P-value 
Age, mean (range) 28.8 (19-37) 32.5 (23-41) 0.14 
Caucasian, n (%) 9 (56.3) 7 (46.7) 0.43 
BMIa, mean (range) 30.6 (16.1 – 54.9) 26.4 (18.7 – 35.0) 0.57 
Lifestyle factors  
complicating 
pregnancy, n (%)b 
6 (42.8) 3 (23.1) 0.25 
Entering with healthy 
pregnancy, n (%) 
2 (12.5) 1 (6.7) 1.00 
Entering with minor 
morbidity, n (%) 
4 (25.0) 6 (40.0) 0.46 
Entering with major 
morbidity, n (%) 
10 (62.5) 7 (50.0)c 0.48 
Primigravida, n (%) 3 (18.8) 1 (6.7)c 0.60 
Multiparous, n (%) 13 (81.3) 13 (92.9)c 0.35 
Private insurance, n 
(%) 
5 (31.3) 1 (6.7) 0.17 
Public insurance / 
Medicaid, n (%) 
9 (56.3%) 12 (85.7%) c 0.08 
Received general 
anesthesia, n (%) 
5 (31.3) 8 (53.3) 0.29 
% Transferred at 
some point in care, n 
(%)d 
5 (31.3) 3 (20.0%) 0.69 
Late / no prenatal 
care, n (%) 
6 (54.5%)e  1 (10.0%)e  0.03 
a BMI at death. Not available for 2 American cases and for 6 Australian cases.  
b  Any alcohol, tobacco or illicit drug consumption during pregnancy. Doesn’t include previous use. Not 
available for 2 American and 2 Australian cases.  
c Not available for 1 case  
d Between facilities. Does not include ICU admission.  
e Not available for 5 cases 
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Table 2: Association between patient characteristics and preventability of maternal death: 
AUSTRALIAN cohort 
 
 Not Preventable 
(N = 4) 
Potentially 
preventable 
 (N=11) 
P-value 
Major Morbidity, 
n (%) 
2 (66.7%)a  5 (45.5%) 0.71 
 
Non-white 
Ethnicity, n (%) 
1 (25.0%) 6 (60.0%)a  0.56 
 
Age ≥35 years, 
n (%)  
3 (75.0%) 3 (27.3%) 0.30 
Private 
Insurance, n (%) 
0 (0%) 1 (9.1%) 1.0 
Transferred 
during care, n 
(%)  
0 (0%) 3 (27.3%) 1.00 
 
Late or no 
prenatal care, n 
(%) a 
0 (0%) 1 (12.5%) 1.0 
Multiparous, n 
(%) 
3 (100.0%)b 10 (90.9%) 1.00 
 
a Not known for 2 non-preventable deaths and 3 potentially preventable deaths  
b Not known for 1 not preventable death 
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Table 3: Association between patient characteristics and preventability of maternal death: AMERICAN 
cohort 
 
 Not Preventable 
(N = 4) 
Potentially 
preventable 
 (N=12) 
P-value 
Major Morbidity, 
n (%) 
3 (75.0%) 7 (58.3%) 1.00 
 
Non-white 
Ethnicity, n (%) 
0 (0%) a 6 (50.0%) 0.23 
 
Age ≥35 years, 
n (%)  
0 (0%) 2 (16.7%) 0.73 
Private 
Insurance, n (%) 
4 (100.0%) 1 (8.3%) 0.003 
Transferred 
during care , n 
(%) 
1 (25.0%) 4 (33.0%) 0.82 
Late or no 
prenatal care, n 
(%)b 
1 (33.0%)  5 (62.5%) 0.55 
Multiparous, n 
(%)           c    
3 (75.0%)  10 (83.3%) 1.00 
 
a Not known for 1 patient  
b  Entry into prenatal care not known for 1 not preventable patient and 4 potentially preventable 
patients  
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Table 4: Association between clinical characteristics and cohort for Louisiana and Queensland 
maternal deaths: all cases  
 
 USA (n= 16)  
 
AUSTRALIA (n=15) Risk difference 
(95% CI); P 
Major Morbidity  10 (62.5%) 7 (50.0%) a 12.5% (-22.8%, 
47.8%); 0.49 
Non-white 6 (40.0%) a 7 (50.0%) a -10.0% (-46.1%, 
26.1%); 0.59 
Age>35 2 (12.5%) 6 (40.0%) -27.5% (-57.1%, 
2.1%); 0.08 
Private insurance 5 (31.3%) 1 (6.7%) 24.6% (-1.4%, 
50.6%); 0.08 
Public insurance / 
Medicaid  
9 (56.3%) 12 (85.7%) a -29.5% (-59.9%, 
1.0%); 0.08 
Transfer during care 5 (31.3%)% 3 (20.0%) 11.3%  (-19.2%, 
41.7%); 0.47 
Late /no prenatal 
care 
6 (54.5%)b 1 (10.0%)b 44.5% (9.7%, 
79.4%); 0.03 
Multiparous 13 (81.3%) 13 (92.9%)a -11.6% (-35.0%, 
11.8%); 0.35 
a Not available for 1 case  
b Not available for 5 cases  
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Table 5: Association between clinical characteristics and cohort for Louisiana and Queensland 
maternal deaths: preventable cases 
 
 USA, n= 12 
 (%) 
AUSTRALIA, n=11 
n (%) 
Risk difference 
(95% CI); P 
Major Morbidity  7 (58.3%) 5 (45.5%) 12.9% (-27.7%, 
53.4%); 0.54 
Non-white 6 (50.0%) 6a (60.0%)  -10.0% (-51.5%, 
31.5%); 0.64 
Age>35 2 (16.7%) 3 (27.3%) -10.6% (-44.3%, 
23.1%); 0.54 
Private insurance 1 (8.3%) 1 (9.1%) -0.8% (-23.8%, 
22.3%); 0.95 
Public insurance / 
Medicaid  
9 (75.0%) 9 (81.8%) -6.8% (-40.3%, 
26.6%); 0.69 
Transfer during care 4 (33.3%) 3 (27.3%) 6.1% (-31.4%, 
43.5%); 0.75 
Late /no prenatal 
care 
5b (62.5%) 1c (12.5%) 50.0% (9.3%, 
90.6%); 0.04 
Multiparous 10(83.3%) 10 (90.9%) -7.6% (-34.7%, 
19.5%); 0.59 
a Not available for 1 case  
b Not available for 4 cases  
c Not available for 3 cases  
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Figure 1: Geographic reach of study  
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Figure 2: Data collection process  
 
OCHSNER HEALTH SYSTEM	 QUEENSLAND HEALTH SYSTEM 	
	
	
HIM = Health Information Management 
DRG = Diagnosis-Related Group 
HSB = Health Statistics Branch 
QHAPDC = Queensland Hospital Admitted Patient Data Collection 
QPDC = Queensland Perinatal Data Collection  
WHO = World Health Organization  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
104 charts identified by HIM with 
obstetric DRG and discharge code of 
deceased during study period 
17 charts reviewed for inclusion  
87 charts excluded for not 
meeting WHO definition of 
maternal death within 42 
days of pregnancy 
1 chart excluded for death 
outside of OHS 
16 charts included in study  
57 unique records identified by 
Queensland HSB by linkage of 
QHAPDC and QPDC to Death 
records data  
18 charts reviewed for inclusion 
2 charts with unknown facility 
code 
28 charts at facilities without 
investigator present 
9 charts destroyed or 
inaccessible at audited sites  
15 charts included in study 
3 charts excluded due to 
unknown cause of death 
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